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Coxiella burnetii is an obligate intracellular bacterial pathogen that undergoes a biphasic 
developmental cycle, alternating between a small cell variant (SCV) and a large cell variant 
(LCV). Despite the remarkable niche and life cycle of C. burnetii, little is known about its modes 
of regulation and the roles that non-coding RNAs play in its growth and development. One such 
element is the intervening sequence (IVS); a 444-nt RNA element that is inserted within helix 45 
of Coxiella’s precursor 23S rRNA. C. burnetii may have acquired IVS through horizontal 
transfer, and it has been subsequently maintained by all strains of C. burnetii through vertical 
transfer. The IVS of C. burnetii contains an ORF that encodes a hypothetical ribosomal S23 
protein (S23p). However, our data show that the S23p-encoding ORF is probably undergoing 
reductive evolution and therefore not expressed in vivo. Additionally, we observed that following 
RNase III-mediated excision, IVS RNA is degraded and levels of the resulting fragments of 23S 
rRNA differ significantly from each other and the 16S rRNA. Since the fragment of 23S rRNA 
that is lowest in quantity may dictate the number of mature ribosomes that are ultimately formed, 
we hypothesize that the biological role of IVS is to moderate Coxiella’s growth by fragmentation 
of its 23S rRNA thereby fostering Coxiella’s tendency towards slow growth and chronic 
infection. Further, we identified fifteen novel Coxiella burnetii sRNAs (CbSRs) using RNA-seq, 
which were verified using Northern analyses. Additionally, some of these CbSRs were 
upregulated in LCVs or during intracellular growth, suggesting adaptive roles in those contexts. 
Furthermore, we also identified and characterized the 6S RNA of C. burnetii and found that it 
accumulated during the SCV phase of the bacterium. The location of ssrS gene and the 
secondary structure of 6S RNA were similar to those of other eubacteria, indicating 
functionality. We also demonstrated that the 6S RNA of C. burnetii interacts specifically with 
RNA polymerase (RNAP). Finally, 6S RNA was highly expressed during intracellular growth of 
C. burnetii indicating that it probably regulates stress response by interacting with RNAP during 
transcription. 
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CHAPTER ONE 
COXIELLA BURNETII AND SMALL NON-CODING REGULATORY RNAS 
A. COXIELLA BURNETII 
I. Introduction 
     Coxiella burnetii is a Gram-negative obligate intracellular bacterium that causes Q 
fever in humans. C. burnetii is extremely infectious, with an ID50 of one to ten bacteria in 
the guinea pig model (1). The bacterium can exist in an endospore-like form, wherein it 
is stable in the environment for long periods. Due to its typical aerosol transmission to 
humans, its historic use as a bioweapon, and low ID50, it is considered a potential 
bioterrorism agent. Hence, the CDC has classified C. burnetii as a category B select 
agent. This disease has gained greater notoriety due a recent outbreak in the 
Netherlands between 2007 and 2010, where more than 4,000 cases of acute Q fever 
were reported (4). The bacterium can be differentiated into phase I and II variants based 
on the length of the O-side chain of lipopolysaccharide (LPS). Strains with a phase I 
phenotype possess LPS with full-length O antigen and are fully virulent. In contrast, 
serial passage of phase I strains in embryonated chicken eggs or tissue culture media 
(i.e., immunologically incompetent backgrounds) causes truncation of the O antigen 
resulting in an avirulent, phase II phenotype and a deep rough LPS (2). 
     Until recently, C. burnetii was only propagated in eukaryotic host cells; a significant 
barrier to genetic manipulation. However, C. burnetii was “freed” from intracellular 
cultivation by development of an acidified citrate cysteine medium (ACCM) (5), which 
was later improved (ACCM2) to allow for isolation of single colonies on semisolid 
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medium (6). This advancement was followed by enhanced tools for genetic 
manipulation, including an improved Himar1-based transposon system (7), a stably 
maintained ori-based shuttle vector (8) and a site-directed mutagenesis strategy (9). 
These advances have provided new opportunities to gain insights into C. burnetii‟s 
regulatory networks, intracellular parasitism and disease pathogenesis. 
II. Q fever 
     Q fever is a zoonotic disease that is typically acquired by inhalation of aerosolized 
soil or animal products contaminated with C. burnetii. This disease has been reported 
worldwide with the exception of New Zealand. The most common reservoirs of this 
pathogen include wild animal species, arthropods and domestic animals (e.g., cattle, 
sheep and goats). Following exposure to the bacterium, the incubation periods varies 
from 2 to 6 weeks. In about half of cases the disease remains asymptomatic. In other 
instances, acute symptomatic Q fever presents with a flu-like illness accompanied by 
high fever, severe retro-orbital headache, malaise, myalgia, atypical pneumonia, and 
hepatitis for 1-2 weeks (10). Although the acute disease is self-limiting, in ~1-5% of the 
cases, it can develop into a chronic infection (11) characterized by endocarditis, 
hepatitis or a post-Q fever fatigue syndrome (12, 13). Endocarditis is the most severe 
manifestation of chronic Q fever, with a high mortality rate (up to 60%) even with timely 
antibiotic treatment (14). 
     Diagnosis of Q fever is difficult due to the generalized flu-like symptoms of the 
disease. Therefore, the diagnosis relies heavily on serology to detect the presence of 
Coxiella antigens or antibodies against them. An indirect immunofluorescence assay, 
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complement fixation or ELISAs are routinely used as diagnostic tests (10, 15). 
Additionally, the nature and titer of antibody can be useful to differentiate between acute 
and chronic infections. During acute infection, IgG antibodies against phase II antigens 
of the bacterium are higher, whereas titers against phase I antigens are higher during 
chronic infection, even though both antibody types are elevated [reviewed in (2)]. 
     Although acute Q fever is most often self-resolving, doxycycline (100 mg twice daily) 
for 2-3 weeks is the first line of treatment to reduce severity of symptoms (11). However, 
chronic Q fever is difficult to treat and requires a prolonged treatment with doxycycline 
(100 mg twice daily) and hydroxychloroquine (600 mg once daily) for 18 months (16). 
     Since Q fever is a zoonotic disease, the chances of infection are high, especially in 
at-risk individuals like abattoir workers. However, a vaccine for Q fever is not widely 
available. Q-Vax, a formalin-inactivated whole-cell preparation is licensed for use in 
Australia (17). Additionally, a soluble, trichloroacetic acid extract of phase I bacteria is 
used as a vaccine in Czechoslovakia (18), and a chloroform-methanol residue vaccine 
is used by the US military (19). 
III. Development cycle 
     C. burnetii undergoes a biphasic developmental cycle consisting of two distinct 
cellular forms (Fig. 1-1). Small cell variants (SCVs) are metabolically inert, highly 
infectious, endospore-like cells of the bacterium that are extremely resistant to harsh 
environmental conditions, including heat, UV light, desiccation, pressure and certain 
disinfectants (20, 21). Following aerosol transmission, the SCV passively enters host  
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Figure 1-1. Developmental cycle of C. burnetii. A small cell variant (SCV) is 
typically internalized  by an alveolar macrophage. Following acidification of the 
vacuole, SCVs metamorphose into large cell variants (LCVs) that are actively 
replicating by day 2. After 5-6 days, LCVs differentiate back to SCVs. By day 12, 
the PV fills the host cell cytoplasm and SCVs are released upon lysis of the host. 
Adapted from (2). 
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phagocytic cells (alveolar monocyte/macrophage) by actin-dependent phagocytosis (22, 
23). Additionally, recent reports show that C. burnetii can invade non-phagocytic cells 
albeit by a different mechanism (24, 25). Phagocytosis of the bacterium results in a 
phagosome that matures through the endosomal cascade by recruiting RAB5 and 
RAB7, resulting in a phagolysosome-like compartment called a parasitophorous vacuole 
(PV) (26). During maturation, the PV undergoes acidification, increases in size and 
delays fusion with the lysosome to enhance the pathogen‟s survival. At this point, the 
PV interacts with autophagosome for nutrients, which along with the acidic pH (~4.5), 
results in the conversion of SCVs to metabolically-active, relatively fragile, large cell 
variants (LCVs) (26, 27). Eventually, the PV fuses with the lysosome; a step that is 
evident by the accumulation of lysosomal enzymes, including cathepsin D (CTSD) and 
lysosomal acid phosphatase (ACP2) (28). Interestingly, the PV membrane contains high 
amounts of cholesterol (twice that of a normal lysosomal compartment) such that 
inhibition of the host‟s cholesterol metabolism negatively affects PV membrane 
formation (29). After 5 to 6 days of infection, LCVs start to differentiate back into SCVs 
with drastic expansion of the PV‟s size to almost consume the host cell‟s volume (30). 
At this stage, the bacterium prolongs it host cell viability by inhibiting apoptotic signaling 
pathways and inducing pro-survival factors (31, 32). After an infection time of ~12 days, 
all the bacteria transform into SCVs that are released upon lysis of the infected cell (30). 
IV. Parasitic genetic elements of C. burnetii 
     Genomes of bacteria are constantly changing by acquiring new DNA through 
horizontal gene transfer and losing by nucleotide deletion (33). These processes are 
more common in environmental bacteria where chances of horizontal gene transfer can 
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occur. On the other hand, host-associated bacteria have little or no chance of acquiring 
new genetic material. Although Coxiella lives within an acidic PV, its genome contains 
an unusually large number of parasitic genetic elements and pseudogenes, which the 
organism may have acquired during a free-living past (34, 35). Such elements include 
31-59 insertion sequences spread across its genome, a putative intein in the C-terminal 
region of the replicative DNA helicase (DnaB) protein and two self-splicing group I 
introns (Cbu.L1917 and Cbu.L1951) along with an intervening sequence (IVS) within the 
23S rRNA gene (Fig. 1-2) [reviewed in (2)]. All of these genetic elements are highly 
conserved in every genotype of Coxiella; however, their exact function is yet to be 
determined. 
a. Intervening sequence 
     Although the 23S rRNA of bacteria is highly conserved, some are fragmented. This 
fragmentation is a result of an IVS (36). IVSs are inserted within the 23S and 16S rRNA 
of certain bacteria and are transcribed along with the rRNA primary transcript but are 
excised quickly thereafter. The size of IVS elements varies from 55 to 759 nt (37, 38). 
Although the sequences of IVSs are not conserved among bacteria, their location of 
occurrence is highly conserved. The mechanism by which IVS elements are inserted 
into the genes of certain bacteria and the reason for targeting rRNA genes are not 
known. Since the ends of these elements are complementary, similar to mobile genetic 
elements, it suggests that IVSs are either inserted into the genome by recombination or 
are footprints of an insertion and subsequent excision event of a transposable element 
(36). The broad, sporadic occurrence of IVS elements suggests that they were probably 
acquired by horizontal gene transfer. Researchers have been trying to understand the  
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Figure 1-2. 23S rRNA gene linkage map of C. burnetii. The position of IVS is 
indicated along with a nested open reading frame (Cbu_2096). Two group I 
introns, L1917 and L1951 that flank a 34-bp exon is also shown. Adapted from 
(3) 
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biological function of this element in bacteria for some time; however, no specific role 
has been ascribed to date. 
     C. burnetii‟s IVS is a 444-nt element that is found inserted in the bacterium‟s 23S 
rRNA (Fig. 1-2), which is fragmented due to excision of the element (39). RNase III, a 
double-stranded specific endoribonuclease, has been shown to be involved in the 
excision of IVS in other bacteria (36-38). The IVS of Leptospira contains an ORF that 
encodes for a hypothetical protein that belongs to the S23p family of proteins. Although 
the function of this protein is not known, it is also found in Xanthomonas and Brucella 
(40). Interestingly, the IVS of C. burnetii also contains a similar ORF (39). The amino 
acid conservation of the S23p encoded in Leptospira and Coxiella IVSs suggest that it 
plays an important role, perhaps in mobility of the element. However, expression of the 
S23p protein in Coxiella is questionable, since no conserved Shine-Dalgarno sequence 
(SD) is observed preceding the start codon, indicating inefficient translation (39). 
     Several benefits of IVSs have been suggested to date. Fragmentation of 23S rRNA 
as a result of IVS excision could result in an increased efficiency of rRNA degradation 
during transition to the SCV phase. This possibility is based on precedence in 
Salmonella, where fragmentation of 23S rRNA resulted in increased degradation of the 
rRNA during stationary phase (41). Moreover, high levels of IVS during exponential 
phase could sequester ribonucleases, thereby regulating their intracellular levels. 
Further, IVS excision from 23S rRNA could also provide a point of regulation of 23S 
rRNA maturation. Another interesting possibility is since IVS elements are more 
common in bacteria that are closely associated with eukaryotic cells (42), they could 
conceivably promote communication between prokaryotes and eukaryotes. Finally, 
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since the presence of IVS elements has been correlated with pathogenicity in strains of 
Yersinia enterocolitica (43), the element might also play a role in somehow regulating 
pathogenesis. 
B. SMALL NON-CODING REGULATORY RNAS 
     Small RNAs (sRNAs) are a heterogeneous group of short, non-coding RNAs ranging 
from 100-400 bases in length that perform a plethora of regulatory functions. They are 
either transcribed as a primary transcript or are formed as a result of processing of a 
larger transcript. sRNAs are known to modulate a variety of processes, including 
transcription, translation, mRNA stability, and DNA maintenance or silencing (44). 
However, most known sRNAs are post-transcriptional regulators that either inhibit or 
enhance translation (44). In contrast to protein-based regulation, sRNA-based 
regulation has multiple advantages. The most obvious is the energy cost, which is 
considerably lower for synthesizing these regulatory molecules. As a result of their small 
size and not having to undergo the extra step of translation, sRNAs are less “expensive” 
to produce than proteins. Additionally, sRNA-mediated regulation is much faster than 
proteins, and they can be used to respond in an extremely sensitive manner. A good 
example is the 5′ UTR element termed a riboswitch, which determines the fate of the 
downstream mRNA based on environmental cues (45). This type of regulation can be 
turned off easily and efficiently since sRNAs are much less stable than regulatory 
proteins (46). Moreover, based on the extent of complementarity with their respective 
targets, sRNAs can fine-tune regulation. For example, trans-encoded sRNAs that share 
incomplete complementarity with their targets can act on multiple targets and can 
differentially regulate translation based on their relative abundance and respective 
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binding affinities (46, 47). In the recent decade, research on discovery and 
characterization of sRNAs has increased greatly. Genome-wide analyses using high-
density tiling arrays and RNA deep sequencing (RNA-seq) have revealed the 
transcriptomes of various pathogenic bacteria and exposed a high abundance of 
sRNAs. Many of these sRNAs are found to play a role in metabolism and virulence of 
these bacteria (48-50). 
I. sRNA regulation in pathogenic bacteria 
     During survival in a hostile environment, bacteria must monitor the environment and 
alter gene expression accordingly. This is especially true for pathogenic bacteria thriving 
in an intracellular niche where nutrients are limited. In this environment, the bacterium is 
also under threat from the constant surveillance of the host‟s immune system, and it 
must withstand elevated concentrations of reactive oxygen species, degradative 
enzymes and various antibacterial constituents of lysosomes. In these instances, 
sRNAs act as excellent mediators that sense environmental cues and alter gene 
expression accordingly. sRNAs can be classified based on the mechanism by which 
they function in bacteria. 
     5' UTR elements are one of the best-studied classes of regulatory sRNAs and 
consist of two diverse groups: riboswitches and RNA thermometers. Basically, these 
elements are present in the 5' UTR of mRNAs and can perceive environmental signals, 
including temperature, pH, metabolite concentrations and stalled ribosomes [reviewed 
in (45)]. RNA thermometers can form secondary structures that are sensitive to 
temperature and affect the translation of the respective downstream mRNA. These 
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elements are very important in pathogenic bacteria. As an example, the 5' UTR of the 
Listeria monocytogenes prfA mRNA forms a secondary structure at lower temperature 
that masks the SD and prevents translation. Upon an increase in temperature to 370C, 
the secondary structure is relaxed, exposing the SD region to bring about translation of 
PrfA, which activates expression of several virulence genes in Listeria monocytogenes 
(51). Likewise, riboswitches can alternate between open and closed structures as a 
function of changing pH and metabolite concentrations, thereby interfering with 
translation of protein(s) encoded downstream [reviewed in (48, 49)]. 
     Another broad class of regulatory sRNAs includes base-pairing sRNAs that are 
either cis- or trans-encoded. Cis-encoded sRNAs are antisense sRNAs that share 
complete complementarity with their target RNAs. The well-studied cis-encoded sRNA 
are expressed from plasmids, transposons or other mobile genetic elements (52). 
However, antisense sRNAs encoded on the chromosome are also being discovered. A 
few of these sRNA are also found to play a role in regulation of virulence gene 
expression (49). For instance, the lesR-1 antisense sRNA encoded on the pSLT 
virulence plasmid of Salmonella enterica directly interacts with the 3' end of the bacterial 
PSLT047 transcript (53). The PSLTO47 protein has been found to be important for the 
intracellular lifestyle of this pathogen (53). 
     On the other hand, trans-encoding sRNAs are encoded at a distal location on the 
chromosome in intergenic regions and thus share only limited complementarity with 
their target mRNAs. The majority of trans-encoded sRNAs are negative regulators that 
act by blocking the ribosome binding site, thereby bringing about translational inhibition, 
mRNA degradation or both (44). An excellent example of trans-encoded sRNA, with 
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relevance to C. burnetii, is Chlamydia‟s IhtA sRNA that represses translation of the 
histone-like protein, Hc1. The increased expression of Hc1 during the late infectious 
phase, as a result of decreased transcription of IhtA, allows the pathogen to differentiate 
to a spore-like elementary body (EB) from a replicative, reticulate body (RB) (54). In 
contrast, trans-encoded sRNAs can also activate translation by base-pairing with an 
inhibitory secondary structure that sequesters the ribosome binding site. Such is the 
case with RNAIII of Staphylococcus aureus that activates α-hemolysis synthesis 
through base pairing with hla mRNA (55). Additionally, RNAIII represses translation of 
staphylococcal protein A and Rot transcription factor by binding to spa and rot mRNAs 
thereby controlling expression of virulence factors (55). Due to limited complementarity 
with their target RNAs, trans-encoded sRNAs usually associate with RNA chaperone 
protein, Hfq (44). Apart from acting as a platform to allow interactions between sRNAs 
and mRNAs, Hfq proteins also protect sRNAs from degradation in the absence of base 
pairing with mRNAs (44). 
     Another class of sRNAs control gene expression by associating with proteins. One of 
the best known examples of this is 6S RNA that interacts with σ70-RNA polymerase 
(RNAP) and regulates transcription at specific promoters. In addition, a unique type of 
an adaptive microbial immune system has recently come to light called clustered 
regularly interspaced short palindromic repeats (CRISPR), which provide resistance 
against viruses and other invading genetic material (56). Recent reports have shown the 
relevance of crRNA in bacteria virulence [reviewed in (49)]. 
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II. 6S RNA 
     6S RNA is a small noncoding RNA that is widely distributed among diverse bacteria. 
The 6S RNA is encoded by the ssrS gene and frequently found in the 5' UTR of ygfA 
(coding for 5-formyltetrahydrofolate cycloligase); a linkage that is widely conserved 
among  and  Proteobacteria (57). 6S RNA has been found to be a global regulator of 
transcription by associating with RNA polymerase (RNAP). Bacterial RNAP is a multi-
subunit core enzyme (α2, β, β', ω) that associates with a sigma subunit (σ) to form a 
holoenzyme (Eσ). The holoenzyme form of RNAP is required for DNA promoter 
recognition and transcription initiation. 6S RNA specifically binds to housekeeping Eσ 
[i.e., Eσ70 in Escherichia coli (58) and EσA in Bacillus subtilis (59)] but has weak or no 
binding with RNAP associated with alternate sigma factors σ38, σ32 or the core RNAP 
enzyme (59, 60). Although 6S RNA is present throughout the growth phase of E. coli, it 
accumulates during stationary phase where over 75% of Eσ70 is bound to 6S RNA (58).  
     6S RNA has a characteristic secondary structure that consists of a single-stranded 
central bubble flanked by a closing stem and terminal loop (57). Although the nucleotide 
sequence of 6S RNA is not conserved, the overall secondary structure and certain base 
pairs and bulges are conserved and are important for its regulatory function (57). For 
example, mutants corresponding to the central bubble of the E. coli 6S RNA were 
unable to bind to RNAP, thus implicating this region in binding (59). The central bubble 
is reminiscent of the structure of DNA in an „open promoter complex‟ when the DNA 
around the start site is melted during initiation of transcription. During its association 
with Eσ70, 6S RNA is lodged in the active site of RNAP. Studies have shown that the 4.2 
region of σ70 that recognizes the -35 element of a DNA promoter is critical for its 
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interaction with 6S RNA. Specifically, eight positively-charged amino acid residues at 
the 4.2 region are essential for 6S RNA binding (61).   
     Studies in E. coli have shown that association of 6S RNA with Eσ70 results in 
decreased transcription from some σ70-dependent promoters. Further, genome-wide 
transcriptome analyses of ssrS null mutants of E. coli showed downregulation of many 
genes, including a marked reduction in genes that encode the translational apparatus 
(62). In some cases, an extended -10 motif and a weak -35 element were identified as 
determinants of 6S RNA-sensitive promoters. However, this observation was not true in 
all cases. Additionally, 6S RNA was also found to activate several σS-dependent 
promoters (63). Due to its poor association with EσS, this effect may be indirect. Taken 
together, these observations indicate that 6S RNA is involved in regulating transcription 
during the transition from exponential to stationary phase during the growth cycle. In 
fact, 6S null mutants displayed reduced fitness during long-term stationary phase (63). 
In Legionella pneumophila, a close relative of C. burnetii, 6S RNA associates with Eσ70 
and is important for intracellular multiplication in human macrophages (64). Moreover, 
ssrS null mutants showed a ten-fold reduction in intracellular growth compared to a wild-
type strain, indicating an adaptive role for 6S RNA that may extend to other intracellular 
pathogens (64). Contrary to what was observed in E. coli, the 6S RNA of L. 
pneumophila mainly serves as a positive regulator affecting genes, including those 
involved in stress adaptation, amino acid metabolism and genes encoding Dot/Icm 
effectors (type IV secretion system substrates) that are important for survival of 
Legionella in its host (64). Furthermore, when stationary E. coli cells encounter new 
nutrient sources and re-enter growth, 6S RNA must be removed from Eσ70. This has 
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been shown to occur by the synthesis of pRNA, wherein RNAP acts as a RNA-
dependent RNA polymerase by using 6S RNA as the template (65). In B. subtilis, 
formation of pRNA induces structural rearrangements that decrease 6S RNA affinity 
towards RNAP resulting in its release (66). 
C. SPECIFIC AIMS, HYPOTHESES AND SIGNIFICANCE 
     As a result of C. burnetii‟s extreme stability in the environment, its ubiquitous nature 
and typical aerosol route of transmission to humans, Q fever is a potential epidemic in 
waiting. The recent outbreak in the Netherlands (2007-2010) is clear evidence of the 
threat that this bacterium poses if sufficient diagnostic and therapeutic tools are not 
available. Understanding the biology of this pathogen will help us in developing effective 
strategies to counter this potential bioterrorism agent.  
    C. burnetii has a large number of parasitic genetic elements for an obligate 
intracellular bacterium [reviewed in (2)]. This is remarkable when one considers the 
reduced chances for horizontal gene transfer in the context of the intracellular niche. 
Moreover, all of these elements are highly conserved in all the genotypes of C. burnetii. 
One such genetic element is the intervening sequence (IVS) present within the 23S 
rRNA gene of C. burnetii. Due to the rare occurrence of IVS in bacteria and its 
conservation among Coxiella genotypes, this selfish genetic element might play a role in 
the pathogen‟s biology. Since IVSs are found in other bacteria that closely associate 
with eukaryotic cells, the results of our study may also be applicable to these bacteria.  
     Despite its remarkable niche and developmental cycle, little is known about 
Coxiella‟s modes of regulation and what role non-coding RNAs play in growth and 
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development. At the start of Coxiella‟s life cycle, the bacterium transitions from an 
extracellular environment (dust, milk, air, etc.) to an intracellular environment within its 
host. During this stage, Coxiella encounters various and sudden changes in 
environmental conditions, including a rapid upshift in temperature (~200C to ~370C), a 
change in osmotic pressure, a downshift in pH (pH 7.0 to pH 4.5) and an increase in the 
concentration of reactive oxygen species. These environmental cues are relevant to 
sRNA-mediated regulation, as they require a rapid response by the pathogen. Soon 
after phagocytosis by an alveolar macrophage, the typical initial host cell in humans, the 
SCV form of Coxiella differentiates into a metabolically-active LCV. sRNA-mediated 
regulation might also be advantageous during the pathogen‟s transition from one 
morphotype to another during development.  
     There are only a few reports to date on the role that regulatory sRNAs play in 
intracellular pathogens, e.g., Chlamydia and Mycobacterium, and nothing has been 
reported for C. burnetii. Hence, identifying the sRNAs of C. burnetii will help elucidate 
the regulatory networks of C. burnetii and improve our understanding of sRNA-mediated 
regulation in intracellular pathogens in general. Therefore, based on these observations 
we hypothesize that RNA elements are involved in regulation of C. burnetii’s 
pathogenesis, metabolism and intracellular parasitism.  
     Our first aim was to characterize the IVS element of C. burnetii. Although Coxiella‟s 
IVS was identified two decades ago, its role in the pathogen‟s biology had not been 
explored. To this end, our first goal was to investigate the ORF present within the IVS 
that potentially encodes a S23p protein. Next, we sought to determine if the IVS RNA of 
C. burnetii is excised by RNase III, similar to what is presumed to occur in other bacteria 
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that have IVS within their 23S rRNA (36-38). The third goal was to determine the 
intrinsic stability of the IVS RNA, since an increased stability would suggest a possible 
adaptive role in Coxiella‟s biology, akin to the two Group I introns encoded in the 23S 
rDNA (67). Finally, since C. burnetii must employ extensive and rapid decay of 
ribosomes during its dramatic transition from LCV to SCV morphotypes, we determined 
if IVS-mediated 23S rRNA fragmentation provides a selective advantage to the 
bacterium during stationary phase, thus establishing a biological function.  
     Since little is known about how Coxiella regulates its biphasic developmental cycle 
and infection of the host, our second aim was to identify sRNAs that may be involved in 
regulating these processes. Our first goal was to analyze sRNAs over the course of 
Coxiella‟s development and identify sRNAs that are important during infection using 
RNA-seq. The next goal was to validate the existence of the identified sRNAs.  
     Preliminary analyses carried out in our lab identified the 6S RNA of C. burnetii. 
Therefore, our third aim was to characterize this sRNA. Since 6S RNA is highly 
expressed during stationary phase in E. coli and during intracellular growth in L. 
pneumophila, our first goal was to determine the expression pattern of 6S RNA as a 
function of C. burnetii‟s growth time and culture conditions. Additionally, studies in E. 
coli and other bacteria have shown that 6S RNA associates with σ70-RNAP. Therefore, 
we elucidated C. burnetii‟s 6S RNA interaction with RNAP. 6S RNA down-regulates 
transcription from a subset of σ70 promoters while activating certain σS promoters, 
based upon work in E. coli. However, in L. pneumophila, a close relative of C. burnetii, it 
positively regulates several genes enhancing growth and virulence of the pathogen. 
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Thus, our final goal was to generate 6S-overexpression and 6S-knockdown mutants of 
C. burnetii to identify genes that are regulated by 6S RNA.  
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CHAPTER TWO 
The intervening sequence (IVS) of Coxiella burnetii; biological role and evolution 
of the RNA element 
A. Abstract 
The intervening sequence (IVS) of Coxiella burnetii, the agent of Q fever, is a 444-nt 
element inserted in helix 45 of the precursor 23S rRNA. The IVS element, in turn, 
contains an open reading frame (ORF) that encodes a hypothetical ribosomal S23 
protein (S23p). Although the IVS is highly conserved among different strains of Coxiella, 
the region immediately upstream of the start codon is prone to change and the S23p-
encoding ORF is apparently undergoing reductive evolution. Moreover, the S23p could 
not be expressed in vitro. Taken as a whole, data suggest that the RNA component of 
the IVS is more biologically significant than the S23p-encoding ORF. We observed that 
IVS excision was mediated by RNase III, and the cleavage sites were mapped to the 
middle of the stem of the predicted secondary structure of the element. Soon after 
excision from 23S rRNA, IVS RNA was found to be degraded. Levels of the two 
resulting 23S rRNA fragments (~1.2 kb and ~1.7 kb) were quantified in axenically-
cultured Coxiella and found to significantly differ from those of the 16S rRNA originally 
derived from the same transcript. Specifically, quantities of the ~1.2-kb fragment (F1) 
were higher than 16S rRNA while those of the ~1.7-kb fragment (F2) were significantly 
lower. Thus, F2 may limit the number of mature ribosomes that are ultimately formed in 
vivo. We therefore hypothesize that the biological role of IVS is to modulate Coxiella‟s 
growth by fragmentation of the 23S rRNA. We further hypothesize that IVS was initially 
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acquired through horizontal transfer and subsequently maintained by all strains of 
Coxiella through vertical transfer due to its adaptive role in fostering Coxiella‟s tendency 
towards slow growth and chronic infection. 
B. Importance 
     Intervening sequences (IVSs) are elements that occur in the 23S rRNA genes of 
many bacteria. Removal of these elements following transcription, results in 
fragmentation of the mature 23S rRNA. Although IVS elements were identified more 
than two decades ago and occur in a wide range of bacterial species, their biological 
function(s) remains elusive. Here, we report that, IVS-mediated fragmentation of 23S 
rRNA in C. burnetii results in two fragments that are differentially regulated, with one of 
them being significantly lower in concentration. We hypothesize that this event 
contributes to the markedly slow growth rate of C. burnetii and fosters its tendency for 
chronic infection of the host.  
C. Introduction 
     Coxiella burnetii, the etiological agent of Q (query) fever, is an obligate intracellular 
pathogen that replicates in a parasitophorous vacuole (PV) (2). Human Q fever is a 
zoonotic disease that is generally acquired through inhalation of contaminated aerosols 
and is characterized by a flu-like illness accompanied by pneumonia and hepatitis (3). 
The bacterium undergoes a biphasic developmental cycle consisting of two cellular 
forms, including an infectious, dormant, small-cell variant (SCV) and a metabolically-
active, large-cell variant (LCV). In spite of its intracellular nature, where chances for 
horizontal gene transfer are minimal, the genome of C. burnetii contains 31 insertion 
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sequence (IS) elements, a putative intein in the C-terminal region of the replicative DNA 
helicase (DnaB) protein and two self-splicing group I introns (Cbu_L1917 and 
Cbu_L1951) along with an intervening sequence (IVS) within the 23S rRNA gene (4).  
     IVSs are parasitic genetic elements that are found in 16S and 23S rRNA genes and 
are transcribed as part of the rRNA precursor. Excision of these elements occurs post-
transcriptionally without ligation of the resulting fragments, which are held together by 
secondary and tertiary structures, thereby maintaining functional integrity of the 50S 
ribosome (5). IVSs have been identified in several bacteria, including Salmonella (6), 
Leptospira (5), Yersinia (7), Campylobacter (8), Proteus and Providencia (9). Within 
these bacteria, IVSs occur only in certain isolates, and in a given bacterial strain not all 
rrn operons contain the IVS (6, 9-11). This sporadic distribution of IVS suggests the 
possibility of horizontal transfer of the element among eubacteria. Although the 
distribution of IVS is random, its location within the 23S rRNA is relatively well-
conserved. The most common sites for insertion of IVS include helices 9, 25 and 45 of 
the postulated secondary structure of E. coli 23S rRNA (12). IVS in both helix 25 and 45 
are observed in Salmonella (13), Helicobacter (14), Proteus and Providencia (9). On the 
other hand, a single copy of IVS is found in helix 45 of Leptospira (5), Yersinia (7), 
Campylobacter (8) and in helix 9 of various alpha-Proteobacteria (15). Each of these 
helices originally consisted of a small tetraloop that was replaced by the extended stem 
loop structure of IVS. The conservation of the IVS insertion sites across species 
indicates that continuity of the 23S rRNA at these positions is probably not necessary 
for ribosomal function.  
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     The IVS of C. burnetii is a 444-nt element that is inserted in the single-copy 23S 
rRNA gene (1). The element is bordered by complementary sequences that can form a 
stable stem-loop structure. IVSs of Salmonella, Leptospira and many species of alpha-
Proteobacteria are known to be cleaved from their respective 23S rRNA by RNase III (5, 
6, 15), an endoribonuclease that cleaves pre-23S and pre-16S rRNA from the 30S 
precursor during rRNA maturation (16). Therefore, we initially hypothesized that 
Coxiella‟s IVS was also excised from its 23S rRNA precursor by RNase III. Additionally, 
IVS of C. burnetii contains an ORF that potentially encodes a ribosomal S23p family of 
hypothetical proteins. Although these proteins have no known function (4), the crystal 
structure of the S23p of Xanthomonas campestris has been solved and found to be a 
homopentamer comprised of four-helix bundles creating a toroidal (doughnut-shaped) 
structure (17). In addition to Xanthomonas, S23p orthologs are also encoded by IVS 
ORFs of Leptospira and Brucella spp. However, previous reports suggested that 
translation of the protein in C. burnetii may be inefficient since no conserved Shine-
Dalgarno sequence (SD) occurs upstream of the start site of the respective ORF (1).  
     At this point, very little is known about the biological role of IVS in bacteria that 
possesses this element. The occurrence of IVS across bacterial species and its 
conservation in all strains of C. burnetii suggest that it might play an adaptive role. 
Interestingly, IVS elements appear to be most common in bacteria that form close 
associations with eukaryotes, possibly promoting communication between bacteria and 
their hosts (18). Such a role is conceivable in Coxiella, especially in view of its 
intracellular niche. A second possible role of IVS is in regulating the pathogenesis of C. 
burnetii. This possibility is supported by an observation in Yersinia, where all pathogenic 
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strains of Y. enterocolitica possessed IVS while non-pathogenic strains did not (7). A 
third possible role for IVS is in regulating the rate of rRNA degradation during C. 
burnetii‟s development cycle. Studies in Salmonella have shown that the rate of 
degradation of 23S rRNA during stationary phase is directly related to the degree of 
IVS-mediated fragmentation of the 23S rRNA (19). Since C. burnetii transitions to an 
endospore-like SCV near the end of its life-cycle, this adaptation would clearly be 
advantageous. 
     The aim of this study was to fully characterize the IVS element of C. burnetii and to 
determine its role in the biology of the bacterium. During our investigation, we 
discovered that the IVS ORF of C. burnetii is undergoing reductive evolution with 
variation in the sequences immediately upstream of the start codon and deletional 
mutagenesis, in different strains of C. burnetii. We also discovered that, similar to other 
bacteria with IVSs in their 23S rRNA, IVS of C. burnetii is also excised by RNase III. 
Moreover, consistent with previous findings, Coxiella‟s IVS RNA was found to be labile 
following excision from 23S rRNA. Together, these observations led us to hypothesize 
that a possible biological function of C. burnetii‟s IVS is the physical fragmentation of 
23S rRNA. Differential levels of the two resulting fragments of 23S rRNA, following IVS 
excision, may limit the number of mature ribosomes that are ultimately formed, thus 
ensuring a slow growth rate for this bacterium.  
D. Materials and Methods 
Axenic cultivation of C. burnetii. Cultures of C. burnetii Nine Mile phase II (RSA439; 
clone 4) were grown in ACCM-2 medium (20) using 0.2-µm-pore size filter-capped 500-
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ml Erlenmeyer flasks containing 80 ml of medium. C. burnetii was inoculated at a 
concentration of 1.6 x 106 genome equivalents per ml (GE/ml). Cultures were incubated 
at 370C in a tri-gas incubator (2.5% O2, 5% CO2, 92.5% N2) with continuous shaking at 
75 RPM (20). Following the first week of growth in a tri-gas incubator, flasks were 
capped and moved to room temperature for generation of SCVs, as previously 
described (21).  
Growth assays of E. coli expressing Coxiella’s IVS. This assay was performed 
essentially as previously described (22). Briefly, the IVS element and ~400 bp of 
flanking sequences were PCR amplified by standard protocol using IVSflank_For and 
_Rev primers (Table 2-1) and cloned into pCR2.1-TOPO per manufacturer‟s instructions 
(Invitrogen) to generate pIVS1. As a control, the IVS was cloned in opposite orientation 
relative to the vector‟s lac promoter to create pIVS2. E. coli (TOP10F′) was transformed 
with pIVS1 or pIVS2 as instructed by the manufacturer (Invitrogen). Resulting E. coli 
strains were grown overnight at 370C in Luria-Bertani (LB) broth containing 100 µg/ml 
ampicillin (LBamp). These cultures were used to inoculate fresh LBamp at a 1:10 (v/v) 
dilution, and the mixture was grown to mid-logarithmic phase (2 h) at 370C.  Isopropyl-
beta-D-thiogalactopyranoside (IPTG) was added to 1 mM and growth was assayed 
spectrophotometrically at 600 nm at hourly intervals for 7 h.  
In vitro coupled transcription-translation (IVTT) of the IVS ORF. Translation of the 
IVS ORF was attempted using an EasyXpress Protein Synthesis kit as instructed by the 
manufacturer (Qiagen). Templates included a PCR product containing the IVS ORF with 
an engineered T7 promoter (Table 2-1; IVS_For+T7 and IVS_Rev) or the same PCR 
product directionally cloned into pCR2.1-TOPO to generate pIVS3. The FluroTechTM  
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Table 2-1. Primers and their respective targets in C. burnetii* 
Target Designation Sequence 
IVS IVSflank_For+T7 
TAATACGACTCACTATAGGGATAGCTGGTTCTCCT
CG     
 IVSflank_For GATAGCTGGTTCTCCTCG 
 IVSflank_Rev CTTTTCCTGGAAGCGTGG 
 IVS_For+T7 
TAATACGACTCACTATAGGTAGCTCACTGGTCGAG
TCG 
 IVS_Rev TGTCAGCATTCGCACTTC 
 IVS_RACE_GSP1  
GATTACGCCAAGCTTACCACACACGCATCTCATCT
GCCGAAC 
 IVS_RACE_GSP2 
GATTACGCCAAGCTTTGGATTGGCAAGCCAAATCC
GTCAAGCAAG 
 IVS_RACE_NGSP1 
GATTACGCCAAGCTTGAAACACTCTGCTTTCCAAA
CCCTTCAGC 
 IVSprobe_F TTTTTTTTTTTTTCATCAGAAGACAGATGAC 
 IVSprobe_R+T7 
TAATACGACTCACTATAGG 
TTTTTTTTTTTTTCATCAGAAGACAGATGGC 
 IVS_qPCR_For ATTGCAATGGGTTCGGCAGATGAG 
 IVS_qPCR_Rev ACAGATGGCAGAAGACTGAGGACA 
RNase III CbuRNaseIII_For TTTTGGATCCAACCATCTTAACAAGTTA 
 CbuRNaseIII_Rev TTTTCCCGGGTCATTGGTCCCGCTCCGT 
CBU_16S 16S_qPCR_For TTCGGGAACCGAGTGACAGGTG 
 16S_qPCR_Rev TCGCTGGCAACTAAGGACGAGG 
CBU_23S 23S Frag1_qPCR_For AACACTGACTGGAGGCCCGAAC 
 23S Frag1_qPCR_Rev AGCCGAAACAGTGCTCTACCCC 
 23S Frag2_qPCR_For GGTGCTTGACTGCGAGAC 
 23S Frag2_qPCR_Rev GGTGGTATCAGCCTGTTATCC 
*The T7 promoter sequence is underlined.  
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GreenLys in vitro Translation Labeling system (Promega) was included in the reaction for 
enhanced detection of translated proteins. Reactions were analyzed on 15% acrylamide 
(w/v) SDS-PAGE gels and visualized using a FLA 3000G Fluorescent Imager (Fujifilm).    
RNase III assay. The C. burnetii RNase III gene (rnc, Cbu_1503; Primers: 
CbuRNaseIII_For and _Rev; Table 2-1) was cloned and purified as previously described 
for the RNA helicase (rhlE) gene (23). An RNase III assay substrate was prepared by 
T7 promoter-mediated in vitro transcription of a PCR product (from PCR primers 
IVSflank_For+T7 and IVSflank_Rev; Table 2-1) using a MAXIscript kit (Ambion), as 
instructed. The resulting RNA was electrophoresed in a 4% acrylamide (w/v) - 8M urea 
gel, and the substrate RNA was excised, eluted overnight at 370C into a buffer 
containing 0.5 M ammonium acetate, 1 mM EDTA, and 0.2% sodium dodecyl sulfate 
and then precipitated with 100% ethanol. RNase III assays were performed for 30 min 
at 370C using 200 nM substrate RNA in RNase assay buffer (50 mM NaCl, 10 mM Tris, 
pH 7.9, 10 mM MgCl2, 1 mM DTT, 450 mM KCl) in the presence of recombinant C. 
burnetii RNase III (30 µM). Positive controls were done using E. coli RNase III (Ambion) 
as per manufacturer‟s instructions. Products of the RNase III assays were analyzed on 
4% acrylamide (w/v) - 8M urea gels.  
Identification of 5′ and 3′ ends of IVS. Ends of the IVS RNA were determined by 5′ 
and 3′ Rapid Amplification of cDNA Ends (RACE) using a SMARTer® RACE 5'/3' kit 
(Clontech) as instructed. RNase III assay products were analyzed on 4% acrylamide 
(w/v) - 8M urea gels from which IVS was purified, before resuspending in RNase-free 
water. Prior to 3′ RACE, IVS RNA was polyadenylated at the 3′ end with E. coli Poly(A) 
polymerase as instructed (NEB). cDNA was generated from IVS RNA before 
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amplification by PCR using gene-specific primers (Table 2-1; IVS_RACE_GSP1, 
IVS_RACE_GSP2) and universal primers. Further, a second nested PCR was 
performed on the 5' RACE primary PCR product using IVS_RACE_NGSP1 (Table 2-1) 
and a universal short primer for increased resolution. PCR products were visualized on 
2% agarose (w/v) gels, purified with a PCR clean-up and gel extraction kit as instructed 
(Clontech) and cloned into pRACE with an In-Fusion HD Cloning kit per manufacturer‟s 
instructions (Clontech). The plasmid content of individual clones was analyzed by 
automated Sanger sequencing at the Genomics Core Facility at the University of 
Montana. 
RNase Protection Assay (RPA). The half-life of IVS RNA was determined using a 
RPA. E. coli TOP10F' (pIVS1) was cultured in LBamp for 16 h at 370C and then used to 
inoculate LBamp at a 1:20 dilution. Following growth for 2 h at 370C, IPTG was added to 
1 mM and cultures were allowed to grow an additional 2 h. Rifampin was added to a 
final concentration of 160 µg/ml and 1-ml samples were taken at 5-min intervals for 35 
min. RNA was purified using TRI Reagent (Ambion) and processed using a RNase 
Protection Assay (RPA) III kit (Ambion) (3 µg total RNA; 800pg IVS probe), as 
previously described (23). Biotinylated IVS RPA probes were prepared using a 
MEGAScript kit, biotin-labeled UTP (Bio 16-UTP; Ambion), and corresponding IVS 
primers (Table 2-1; IVSprobe_F and IVSprobe_R+T7). Relative levels of 23S and 16S 
rRNAs in C. burnetii over the course of its life cycle were also determined using a RPA. 
C. burnetii was cultured in ACCM-2, and DNA and RNA were isolated from the same 
flask at 3, 5, 7, 10, 12, 14, 17 and 21 d using a DNeasy Blood and Tissue kit (Qiagen) 
and Ribopure kit (Amibion), respectively, as per manufacturer‟s instructions. Resulting 
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RNA was treated with TURBO DNase (Ambion), precipitated with 100% ethanol and 
quantified by spectrophotometry. Biotinylated RNA probes for 16S, 23S fragment 1 (F1) 
and 23S fragment 2 (F2) were prepared as above, using corresponding primers (Table 
2-1; 16S_qPCR_For and _Rev, 23S Frag1_qPCR_For and _Rev, 23S 
Frag2_qPCR_For and _Rev). RNA (250 ng) and corresponding probes (25 pg) were 
processed using RNase Protection Assay (RPA) III kit (Ambion), as previously 
described (23).  
Quantitative real-time PCR (qRT-PCR). DNA and RNA were isolated from the same 
cultures at 0, 1, 7, 10, 13, 16, 19 and 22 d as described in „RNase Protection Assay 
(RPA)‟ and 20 ng of RNA from each growth time-point was converted to cDNA using an 
iScript cDNA synthesis kit (Bio-Rad), as instructed by the manufacturer. Genome 
numbers were determined by quantitative PCR (qPCR) with a primer set specific to the 
C. burnetii rpoS gene (24). cDNA (diluted 100-fold) was used to perform quantitative 
real-time PCR (qRT-PCR) with corresponding primer sets (Table 2-1), as previously 
described (22). Amplified cDNA was normalized to respective genome numbers. 
E. Results and Discussion 
Evolution of the IVS ORF 
     Earlier attempts by our lab to clone the IVS of C. burnetii Nine Mile (NM) phase I 
(strain RSA493) in E. coli only generated clones whose insert was in opposite 
orientation to the vector‟s lac promoter, implying that the element was toxic to E. coli. 
However, a previous report showed that E. coli expressing the IVS of S. typhimurium 
did not display any growth defects (25). To clarify this disparity, the IVS of C. burnetii 
37 
 
NM phase II (strain RSA439) with ~400 flanking bases was cloned into pCR2.1-TOPO 
in both orientations relative to the vector‟s lac promoter to produce pIVS1 and pIVS2, 
respectively. E. coli strains harboring pIVS1 or pIVS2 were induced with IPTG and their 
growth rates monitored spectrophotometrically for 7 h. Contrary to what we previously 
observed, the growth rate of E. coli (pIVS1) was not significantly different from E. coli 
(pIVS2) or E. coli containing the pCR2.1-TOPO cloning vector alone (Fig. 2-1). These 
results suggested that the IVS elements of the two C. burnetii strains were distinct, with 
that of RSA493 possibly toxic and RSA439 innocuous to E. coli.  
    Interestingly, the C. burnetii IVS contains an ORF that encodes a 14.2-kDa protein 
that belongs to the ribosomal_S23 family of hypothetical proteins (S23p). Although IVS 
of C. burnetii was not found to be homologous to IVS of other bacteria, phylogenetic 
analyses performed using the predicted amino acid sequence of Coxiella‟s S23p, 
showed that the protein is most closely related to a homolog encoded in the IVS of 
Haemophilus sp. with 71% identity (Fig. 2-2). As previously reported, a number of C. 
burnetii S23p homologs are also found in pathogenic Leptospira (1). These results 
prompted us to determine whether the C. burnetii S23p protein could be expressed in 
vitro using a coupled transcription-translation system from an E. coli S30 extract. 
However, we were unable to detect an insert-specific protein of ~14.2 kDa by this 
approach, indicating that the protein is not expressed in vitro (data not shown). These 
results were not surprising, since the absence of a conserved SD site upstream of the 
ORF was previously noted (1). In agreement with our data, the S23p protein was not 
identified in proteomic analyses of C. burnetii cell lysates and secreted molecules, 
implying that this protein is probably not expressed in vivo as well (26, 27).  
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Figure 2-1. Effect of the C. burnetii (RSA439) IVS on E. coli’s growth. E. coli 
(TOP10F′) expressing: IVS (square), control RNA (circle) or the empty vector 
(pCR2.1-TOPO; triangle) were induced with IPTG (1 mM) and assayed 
spectrophotometrically at 600 nm for growth at 37
0
C. A typical representative of 
two assays is shown.  
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Figure 2-2. Phylogenetic analysis of the twelve top BLASTp hits to C. burnetii’s 
S23p protein.  Neighbor-joining trees were built from predicted amino acid sequences 
of IVS ORF-encoded S23p superfamily proteins using MEGA5. Bootstrap values (1,000 
replicates) are indicated at the nodes. Amino acid sequence identities ranged from 54 
to 71% with C. burnetii‟s S23p protein.  
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     In silico analysis of the IVS regions of approximately 80 C. burnetii isolates was done 
to investigate the cloning disparity we observed when IVS elements were cloned from 
strains RSA493 and RSA439. Interestingly, results showed that some C. burnetii strains 
possess deletions in the sequence immediately upstream of the S23p ORF. As a rule, 
the 5′ region of the IVS consisted of a potential SD sequence of AGAAGA followed by 
three, tandem heptameric repeats (GACAGAT) upstream of the start codon of the S23p 
ORF (Fig. 2-3). There is an additional heptameric repeat with a degenerate nucleotide 
at its 3′ end (GACAGAA) prior to the predicted ATG of the S23p ORF (Fig. 2-3). Upon 
analysis of different strains of C. burnetii, a disparity in the number of heptameric 
repeats was observed. In Dugway, RSA331 and Q212 strains, three sets of heptameric 
repeat units were found, whereas in strains RSA493, Q154 and Q177 only two sets of 
the repeats were present. This disparity was also found to exist between RSA493 and 
RSA439, wherein RSA439 has three sets of heptameric repeat units (not shown) while 
RSA493 has only two sets (Fig. 2-3). This variation may explain why E. coli clones 
prepared from the IVS elements of the two strains behaved so differently.  Specifically, 
those prepared from RSA439 (with 3 repeats) were non-toxic to E. coli and did not 
affect growth (Fig. 2-1). Apart from the SD region for this locus being poor, the presence 
of an extra repeat unit would move the start codon away from the putative AG-rich SD 
region, thus reducing the chance of translation of the ORF. Interestingly, another C. 
burnetii strain (3257) was found to have a large, 176-bp deletion its S23p ORF (not 
shown), implying that the protein-coding segment of the IVS is undergoing reductive 
evolution and is expendable. Taken together, these observations lead us to conclude 
that irrespective of the number of repeat units, the S23p ORF is probably not expressed  
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Dugway  CATCAGAAGACAGATGACAGATGACAGATGACAGAAATATGAAAAAAGAAATATCTAGCTTTGA 
RSA331  CATCAGAAGACAGATGACAGATGACAGATGACAGAAATATGAAAAAAGAAATATCTAGCTTTGA 
Q212    CATCAGAAGACAGATGACAGATGACAGATGACAGAAATATGAAAAAAGAAATATCTAGCTTTGA 
Q154    CATCAGAAGACAGAT-------GACAGATGACAGAAATATGAAAAAAGAAATATCTAGCTTTGA 
RSA493  CATCAGAAGACAGAT-------GACAGATGACAGAAATATGAAAAAAGAAATATCTAGCTTTGA 
Q177    CATCAGAAGACAGAT-------GACAGATGACAGAAATATGAAAAAAGAAATATCTAGCTTTGA 
        ***************       ****************************************** 
Figure 2-3. Multiple sequence alignment of the 5′ region of C. burnetii’s IVS. 
Corresponding sequences of selected C. burnetii strains (shown on the left) were aligned 
using ClustalX. Bases in grey represent a potential SD region. Arrows indicate a direct 
heptameric repeat, while a dashed line shows deletion of one of the repeats. ATG (in bold) 
represents the start codon of the S23p ORF, as predicted by Afseth et al. (1) 
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in vivo. Even though the IVS element is highly conserved among different strains of C. 
burnetii with uniform occurrence and 99% sequence identity, the region immediately 
upstream of the start codon is prone to minor changes and the protein S23p ORF is 
undergoing reductive evolution. These results lead us to hypothesize that the RNA 
component of the IVS is more biologically significant than the S23p protein.  
In vitro processing of C. burnetii IVS by RNase III. 
     The IVS of C. burnetii was first described by Afesth et al. as a 444-nt element that is 
excised to yield a mature, fragmented yet functional 23S rRNA (1). The IVS element is 
initially found inserted into helix 45 of C. burnetii‟s precursor 23S rRNA. IVS RNA of C. 
burnetii (RSA493) forms a stable stem-loop secondary structure (∆G= -144.36 kCal/mol) 
due to the presence of complementary sequences at its termini (Fig. 2-4). The terminal 
inverted repeats (IRs) form a 28-bp stem with complete complementarity except for a 
single mismatch and a bulge. The bulge results from a missing heptameric tandem 
repeat in this strain (Fig. 2-4). IVS elements of other bacteria are also associated with 
23S rRNA genes and are excised by RNase III (5, 6, 15), an endoribonuclease that 
cleaves rRNA precursors during their maturation (28). To determine if this ribonuclease 
is responsible for excision of IVS from the 23S rRNA precursor of C. burnetii, we 
performed an in vitro assay using recombinant C. burnetii RNase III. A T7-transcribed in 
vitro RNase III substrate RNA containing IVS and ~400 nt of flanking sequences was 
used in the assay with either recombinant C. burnetii RNase III or commercial E. coli 
RNase III. Since RNase III cleavage is nonspecific at low ionic strength (29), we tested 
cleavage efficiencies at several ionic strengths (data not shown) and a final ionic 
concentration of 0.5 M (50 mM NaCl plus 450 mM KCl) was used in the reaction. When  
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Figure 2-4. Predicted secondary structure of the C. burnetii IVS using 
Mfold. (ΔG = -144.36 kCal/mol). An ORF (CBU_2096) encoding a potential 
S23p protein is shown in blue.   
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products of the RNase III assay were analyzed on a polyacrylamide gel, three distinct 
RNA bands corresponding to the IVS (444 nt) and its flanking sequences (393 and 364 
nts) were observed (Fig. 2-5). These results indicate that C. burnetii RNase III is 
capable of cleaving IVS in vitro and most probably does so in vivo. Identical RNA 
fragments were observed in reactions containing E. coli RNase III but were absent from 
the negative control (Fig. 2-5).  
Characterization of the 5′ and 3′ ends of IVS. 
     Afesth et al. characterized the IVS by identifying the sequence that was not a portion 
of the 23S rRNA (1). To determine the exact ends of the IVS element, we performed 5′ 
and 3′ Rapid Amplification of cDNA Ends (RACE) analysis on IVS RNA isolated from 
the RNase III assay products. At least 7 clones were isolated from each reaction and 
sequenced. The sequence of the 5′ and 3′ ends of IVS RNA are shown with black dots 
indicating experimentally determined locations of the RNase III cleavage sites (Fig. 2-
6A). While the 3′ end was uniform, the 5′ end showed a preferred cleavage site plus 
three minor, additional sites. When the sites of cleavage were mapped on the predicted 
secondary structure of IVS, it was found to be in the middle of the stem structure at 
about 9 bases from the 5′ end and about 15 bases from the 3′ end of the predicted IVS 
RNA sequence (Fig. 2-6B). Following cleavage, the remaining stem portion of the IVS 
could either be retained in the mature 23S rRNA that holds the rRNA pieces together, 
as observed in Leptospira (5, 8), or it could be trimmed to the correct size by 
exonucleases. One example of such a ribonuclease is RNase T, which plays a role in 3 ′ 
maturation of E. coli‟s 23S rRNA and is also present in C. burnetii (16). However, an 
exoribonuclease involved in maturation of 5′ ends has not yet been identified (16).  
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Figure 2-5. In vitro processing of the C. burnetii IVS by RNase III. (A) Map of the 
RNA substrate used in RNase III assays, consisting of a segment of 23S rRNA with the 
IVS and proximal flanking sequences (sizes shown). (B) Acridine orange-stained 
polyacrylamide gel [4% acrylamide (w/v)- 8M urea] showing cleavage products of 
substrate RNA following treatment with recombinant C. burnetii RNase III. Three 
discrete fragments of sizes corresponding to the substrate RNA (arrowed) were 
observed. Positive [E. coli RNase III (Ambion)] and negative (no RNase III) control 
reactions are shown for comparison. 
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Figure 2-6. Characterization of C. burnetii’s IVS termini by 5′- and 3′-RACE 
analysis. (A) Sequence of the 5′ and 3′ ends of the IVS are shown. Each black dot 
indicates the last base in an individual sequence analysis of a cloned RACE PCR 
product. (B) Schematic representation of RNase III processing sites on the stem of 
the IVS RNA of C. burnetii (RSA493). Black arrows depict the processing sites as 
predicted by 5′- and 3′-RACE analyses. The relative location of the S23 ORF 
(CBU_2096) is indicated by a grey arrow.  
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In vivo stability of IVS RNA.  
     Previous work by our laboratory showed that Coxiella‟s introns, Cbu.L1917 and 
Cbu.L1951, are spliced from the precursor 23S rRNA and demonstrate remarkable 
stability (~11 min) in an E. coli background, suggesting a possible adaptive role in 
Coxiella‟s biology (23). Since the IVS is uniformly present and highly conserved among 
all strains of C. burnetii, an adaptive role might also be attributed to IVS RNA. To 
determine the intrinsic stability of the IVS RNA, we performed an in vivo stability assay 
in an E. coli model. E. coli (pIVS1) was cultured, expression induced by IPTG, and cells 
sampled after transcription was stopped with rifampicin. RPAs performed on RNAs 
isolated from these samples showed the half-life of IVS RNA to be ~4 min (Fig. 2-7). 
Considering that the global average half-life of mRNA in E. coli is ~5.7 min (30), these 
results suggest that IVS RNA doesn‟t display extraordinary intrinsic stability like 
Coxiella‟s intron RNAs. However, since the RNase activities of E. coli may be different 
from that of C. burnetii, we also quantified levels of IVS RNA in C. burnetii to determine 
its stability in vivo. C. burnetii was cultured in axenic medium for 22 d and IVS RNA 
levels were measured by performing qRT-PCR on total RNAs purified from the 
bacterium at 72-h intervals, using primers specific to the IVS (Table 2-1). qPCR was 
also performed on genomic DNA isolated at the same time-points to calculate the 
amount of IVS RNA on a per-genome basis. Results showed that IVS RNA was highest 
at 1 d (Fig. 2-8), or the beginning of the exponential phase of Coxiella (20). Since 
rRNAs are transcribed during this phase and mature 23S rRNA is formed following 
excision of IVS, the increased level correlates with increased synthesis of 23S rRNA. As 
the bacterium reached stationary phase (~4 d) (20), levels of IVS significantly declined  
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Figure. 2-7. In vivo half-life of C. burnetii’s IVS RNA in E. coli. A representative 
example of the in vivo IVS half-life as determined by RPA is shown. (A) RPA blot with 
the IVS band (508 bases) indicated by an arrowhead. (3 µg RNA per lane and 800 pg 
of IVS probe were used). Lanes 1 and 2 show controls with biotin-labeled IVS probe 
in the absence or presence of RNase A/T1, respectively; Lanes 3-10 show RNA 
isolated at 5-min intervals from 0-35 min following rifampin treatment. (B) 
Densitometric analysis of IVS bands in blot lanes 3-10 versus time of collection 
following rifampin treatment. The equation for the exponential curve and the R
2
 value 
are inset and yields an IVS half-life of 3.9 min. 
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Figure 2-8. Levels of C. burnetii rRNAs and IVS RNA over time in culture. (A) q-PCR 
data showing C. burnetii genome equivalents per ml (GE/ml) during growth in axenic 
medium. (B) qRT-PCR data showing numbers of 16S rRNAs (striped bars), 23S F1 (black 
bars), 23S F2 (white, speckled bars) and IVS RNAs (grey bars) on a per genome basis. 
Data represent the means of six independent experiments ± S.D., except IVS data at 0 d, 
which represent the mean of three determinations ± S.D.  
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and subsequently became insignificant (Fig. 2-8). These results were consistent with 
previous reports for IVS elements of other bacteria, where IVS RNAs were not 
detectable by Northern analysis during growth, indicating reduced stability following 
excision from 23S rRNA (6, 8). Taken together, these results suggest that soon after 
excision from the 23S rRNA, IVS RNA is degraded in vivo, as observed in vitro.  
Differential levels of 23S rRNA fragments following IVS excision. 
     The 23S rRNA of eubacteria is highly conserved, however, fragmentation caused by 
IVS elements does not appear to affect ribosome function (15). In fact, IVS elements 
occur within the 23S rRNA genes of several bacteria, including various Leptospira (5), 
Salmonella (6) and Yersinia (7). Although fragmentation does not affect the viability of 
these bacteria, it has been shown to affect the rate of 23S rRNA degradation in 
Salmonella as cells reach stationary phase (19). In fact, there appears to be a direct 
correlation between the degree of IVS-mediated fragmentation and the rate of 23S 
rRNA degradation, conferring a selective advantage to the bacterium. A similar 
adaptation could conceivably be advantageous to C. burnetii as it transitions to the 
small, endospore-like, SCV phase. To investigate this possibility and to help elucidate 
the biological function of IVS, we compared quantities of 16S rRNA to the two fragments 
of 23S rRNA by qRT-PCR. As a result of IVS excision, the 23S rRNA of C. burnetii is 
fragmented into ~1.2-kb and ~1.7-kb segments, i.e., fragment 1 (F1) and fragment 2 
(F2), respectively. Results showed that on a per-genome basis,  levels of 16S rRNA 
increased significantly at 1 d, i.e. at the beginning of log-phase (P < 0.0001), and fell 
significantly (P < 0.0001) as cells transitioned to stationary phase (4 d) (Fig. 2-8B).  
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Thereafter, levels of 16S rRNA remained stable with no significant changes from 4-22 d. 
Similar to what was observed with 16S rRNA, levels of F1 and F2 increased significantly 
(P<0.0002) at the beginning of log-phase (1 d), decreased significantly (P < 0.0001) as 
the cells approached stationary phase (4 d), and were stable between 4-22 d with no 
significant differences (Fig. 2-8B). However, the quantities of F1 and F2 appeared to be 
considerably different from one another. Since C. burnetii‟s structural rRNAs are all 
encoded by a single-copy operon, they would be expected to be at parity, at least 
initially following transcription. Surprisingly, at each sampling time point, quantities of F1 
were significantly higher (P<0.0007) than 16S rRNA (up to ~8 fold on day 7). On the 
other hand, levels of F2 were significantly lower (P < 0.0001) than 16S rRNA (up to ~50 
fold on day 1). These results were corroborated by RPAs performed on total RNAs 
purified from C. burnetii isolated at similar time points (Fig. 2-9).   
     The differential stability of F1 and F2 was a surprising result, since studies in 
Salmonella have shown that following fragmentation, both segments of its 23S rRNA 
are equally prone to degradation near stationary phase. Since rRNA transcription, 
maturation and ribosome assembly are coupled in bacteria, it is conceivable that 
fragmentation of 23S rRNA might occur in the context of the ribosome. In such a case, 
following excision of IVS, F1 might be incorporated into the ribosome and thus protected 
from RNase degradation. Whereas, F2 might be more labile since it is relatively larger in 
size (~1.7 kb versus ~1.2 kb) and has two introns that must also be spliced out during 
maturation. These results show that following transcription and maturation each rRNA  
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Figure. 2-9. Differential levels of C. burnetii rRNA species during growth. Levels 
of 16S rRNA and two fragments of 23S rRNA (23S F1 and 23S F2) were determined 
by RPA. (A) RPA blot showing F2, 16S and F1 bands. (In each case, 250 ng of RNA 
per lane and 25 pg of probe were used). Lanes 1 and 2 are control lanes with biotin-
labeled probe in the absence or presence of RNase A/T1, respectively; Lanes 3-10 
show RNA isolated over 3-21 d. (B) Densitometric analysis of 16S rRNA (striped 
bars), 23S F1 (black bars) and 23S F2 (white, speckled bars) in blot lanes 3-10 
versus time of collection.  
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fragment is under the influence of a unique micro environment that determines its 
ultimate fate. 
   Considering that an equal number of each rRNA species (5S, 16S, 23S) is 
incorporated into a mature ribosome, the excess rRNA is undoubtedly degraded. F2, 
which is the lowest in relative quantity, would effectively limit the number of mature 
ribosomes that are ultimately formed. It is conceivable that this constraint could 
contribute to growth modulation in C. burnetii. We therefore hypothesize that IVS-
mediated fragmentation of 23S rRNA is adaptive by virtue of the variable stability of the 
resulting 23S rRNA fragments, which contributes to the slow growth rate of C. burnetii. 
In turn, the slow growth rate fosters Coxiella‟s tendency towards chronic infection and 
persistence in the host (22). 
Phylogeny of C. burnetii’s IVS 
     Although 23S rRNAs are highly conserved among eubacteria, the occurrence of IVS 
within 23S rRNA is sporadic. In Leptospira, IVS occurs in only some species and a few 
strains of that species (5). While in Salmonella, with multiple rrn operons, IVS is present 
in only certain copies of the 23S rRNA genes (6). Additionally, in the LT2 strain of S. 
typhimurium, three distinct IVSs were found to occur in its 23S rRNA genes (11). This 
scattered distribution of IVS suggests the possibility of horizontal transfer. Moreover, 
Ralph and McClelland investigated the phylogeny of this element in species of 
Leptospira and showed evidence of natural horizontal transfer of IVS between species 
of this genus (31). Horizontal transfer is known to be an important process in evolution 
with well-established roles such as acquisition of antibiotic resistance genes (32) and 
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movement of group I and II introns between species (33). However, when the presence 
of IVS among different strains of C. burnetii was determined, it was found to be present 
in all strains with 99% sequence identity. In addition, the GC content of C. burnetii‟s IVS 
is ~36% while that of its genome is ~42.5%. These observations suggest that modern 
C. burnetii strains may have acquired the element by vertical transfer from a common 
ancestor. Recently, Duron et al have shown that all known strains of C. burnetii have 
evolved from a Coxiella-like organism hosted by soft ticks of the Ornithodoros and 
Argas genera (34). They state that the maternally-inherited endosymbiont of ticks, a 
Coxiella-like organism, may have evolved into a highly-infectious pathogen of 
vertebrates, by acquisition of virulence genes through horizontal transfer from co-
infecting pathogens (34). Keeping this in mind, it is conceivable that C. burnetii initially 
acquired its IVS through horizontal transfer before or during specialization to a 
vertebrate host. Thereafter, IVS was probably maintained within the genus by vertical 
transfer as a result of selective pressures imposed by the intracellular niche and the 
adaptive role of modulated growth imparted by the element.  
F. Acknowledgements  
We are grateful to Kip Barhaugh and Jeff Guccione for technical assistance. This work 
was supported by NIH grant R21AI078125 (to MFM). 
 
 
 
 
 
55 
 
G. References 
1. Afseth G, Mo YY, Mallavia LP. 1995. Characterization of the 23S and 5S rRNA 
genes of Coxiella burnetii and identification of an intervening sequence within the 
23S rRNA gene. J Bacteriol 177:2946-2949. 
2. Voth DE, Heinzen RA. 2007. Lounging in a lysosome: the intracellular lifestyle of 
Coxiella burnetii. Cell Microbiol 9:829-840. 
3. Maurin M, Raoult D. 1999. Q fever. Clin Microbiol Rev 12:518-553. 
4. Minnick MF, Raghavan R. 2011. Genetics of Coxiella burnetii: on the path of 
specialization. Future Microbiol 6:1297-1314. 
5. Ralph D, McClelland M. 1993. Intervening sequence with conserved open 
reading frame in eubacterial 23S rRNA genes. Proc Natl Acad Sci U S A 
90:6864-6868. 
6. Burgin AB, Parodos K, Lane DJ, Pace NR. 1990. The excision of intervening 
sequences from Salmonella 23S ribosomal RNA. Cell 60:405-414. 
7. Skurnik M, Toivanen P. 1991. Intervening sequences (IVSs) in the 23S 
ribosomal RNA genes of pathogenic Yersinia enterocolitica strains. The IVSs in 
Y. enterocolitica and Salmonella typhimurium have a common origin. Mol 
Microbiol 5:585-593. 
8. Konkel ME, Marconi RT, Mead DJ, Cieplak W, Jr. 1994. Identification and 
characterization of an intervening sequence within the 23S ribosomal RNA genes 
of Campylobacter jejuni. Mol Microbiol 14:235-241. 
56 
 
9. Miller WL, Pabbaraju K, Sanderson KE. 2000. Fragmentation of 23S rRNA in 
strains of Proteus and Providencia results from intervening sequences in the rrn 
(rRNA) genes. J Bacteriol 182:1109-1117. 
10. Hsu D, Zee YC, Ingraham J, Shih LM. 1992. Diversity of cleavage patterns of 
Salmonella 23S rRNA. J Gen Microbiol 138:199-203. 
11. Mattatall NR, Sanderson KE. 1996. Salmonella typhimurium LT2 possesses 
three distinct 23S rRNA intervening sequences. J Bacteriol 178:2272-2278. 
12. Noller HF. 1984. Structure of ribosomal RNA. Annu Rev Biochem 53:119-162. 
13. Pabbaraju K, Miller WL, Sanderson KE. 2000. Distribution of intervening 
sequences in the genes for 23S rRNA and rRNA fragmentation among strains of 
the Salmonella reference collection B (SARB) and SARC sets. J Bacteriol 
182:1923-1929. 
14. Hurtado A, Clewley JP, Linton D, Owen RJ, Stanley J. 1997. Sequence 
similarities between large subunit ribosomal RNA gene intervening sequences 
from different Helicobacter species. Gene 194:69-75. 
15. Evguenieva-Hackenberg E, Klug G. 2000. RNase III processing of intervening 
sequences found in helix 9 of 23S rRNA in the alpha subclass of Proteobacteria. 
J Bacteriol 182:4719-4729. 
16. Deutscher MP. 2009. Maturation and degradation of ribosomal RNA in bacteria. 
Prog Mol Biol Transl Sci 85:369-391. 
17. Lin LY, Ching CL, Chin KH, Chou SH, Chan NL. 2006. Crystal structure of the 
conserved hypothetical cytosolic protein Xcc0516 from Xanthomonas campestris 
57 
 
reveals a novel quaternary structure assembled by five four-helix bundles. 
Proteins 65:783-786. 
18. Baker BJ, Hugenholtz P, Dawson SC, Banfield JF. 2003. Extremely 
acidophilic protists from acid mine drainage host Rickettsiales-lineage 
endosymbionts that have intervening sequences in their 16S rRNA genes. Appl 
Environ Microbiol 69:5512-5518. 
19. Hsu D, Shih LM, Zee YC. 1994. Degradation of rRNA in Salmonella strains: a 
novel mechanism to regulate the concentrations of rRNA and ribosomes. J 
Bacteriol 176:4761-4765. 
20. Omsland A, Beare PA, Hill J, Cockrell DC, Howe D, Hansen B, Samuel JE, 
Heinzen RA. 2011. Isolation from animal tissue and genetic transformation of 
Coxiella burnetii are facilitated by an improved axenic growth medium. Appl 
Environ Microbiol 77:3720-3725. 
21. Sandoz KM, Sturdevant DE, Hansen B, Heinzen RA. 2014. Developmental 
transitions of Coxiella burnetii grown in axenic media. J Microbiol Methods 
96:104-110. 
22. Raghavan R, Hicks LD, Minnick MF. 2008. Toxic introns and parasitic intein in 
Coxiella burnetii: legacies of a promiscuous past. J Bacteriol 190:5934-5943. 
23. Hicks LD, Warrier I, Raghavan R, Minnick MF. 2011. Ribozyme stability, exon 
skipping, and a potential role for RNA helicase in group I intron splicing by 
Coxiella burnetii. J Bacteriol 193:5292-5299. 
58 
 
24. Coleman SA, Fischer ER, Howe D, Mead DJ, Heinzen RA. 2004. Temporal 
analysis of Coxiella burnetii morphological differentiation. J Bacteriol 186:7344-
7352. 
25. Gregory ST, O'Connor M, Dahlberg AE. 1996. Functional Escherichia coli 23S 
rRNAs containing processed and unprocessed intervening sequences from 
Salmonella typhimurium. Nucleic Acids Res 24:4918-4923. 
26. Coleman SA, Fischer ER, Cockrell DC, Voth DE, Howe D, Mead DJ, Samuel 
JE, Heinzen RA. 2007. Proteome and antigen profiling of Coxiella burnetii 
developmental forms. Infect Immun 75:290-298. 
27. Skultety L, Hajduch M, Flores-Ramirez G, Miernyk JA, Ciampor F, Toman R, 
Sekeyova Z. 2011. Proteomic comparison of virulent phase I and avirulent phase 
II of Coxiella burnetii, the causative agent of Q fever. J Proteomics 74:1974-
1984. 
28. Dunn JJ, Studier FW. 1973. T7 early RNAs and Escherichia coli ribosomal 
RNAs are cut from large precursor RNAs in vivo by ribonuclease 3. Proc Natl 
Acad Sci U S A 70:3296-3300. 
29. Dunn JJ. 1976. RNase III cleavage of single-stranded RNA. Effect of ionic 
strength on the fideltiy of cleavage. J Biol Chem 251:3807-3814. 
30. Bernstein JA, Khodursky AB, Lin PH, Lin-Chao S, Cohen SN. 2002. Global 
analysis of mRNA decay and abundance in Escherichia coli at single-gene 
resolution using two-color fluorescent DNA microarrays. Proc Natl Acad Sci U S 
A 99:9697-9702. 
59 
 
31. Ralph D, McClelland M. 1994. Phylogenetic evidence for horizontal transfer of 
an intervening sequence between species in a spirochete genus. J Bacteriol 
176:5982-5987. 
32. Krawiec S, Riley M. 1990. Organization of the bacterial chromosome. Microbiol 
Rev 54:502-539. 
33. Dujon B. 1989. Group I introns as mobile genetic elements: facts and 
mechanistic speculations--a review. Gene 82:91-114. 
34. Duron O, Noel V, McCoy KD, Bonazzi M, Sidi-Boumedine K, Morel O, Vavre 
F, Zenner L, Jourdain E, Durand P, Arnathau C, Renaud F, Trape JF, 
Biguezoton AS, Cremaschi J, Dietrich M, Leger E, Appelgren A, Dupraz M, 
Gomez-Diaz E, Diatta G, Dayo GK, Adakal H, Zoungrana S, Vial L, Chevillon 
C. 2015. The Recent Evolution of a Maternally-Inherited Endosymbiont of Ticks 
Led to the Emergence of the Q Fever Pathogen, Coxiella burnetii. PLoS Pathog 
11:e1004892. 
 
 
 
 
 
 
 
 
 
60 
 
CHAPTER THREE 
Identification of Novel small RNAs of Coxiella burnetii  
As published in: PLoS One. 2014 Jun 20;9(6):e100147. doi: 
10.1371/journal.pone.0100147 
A. Abstract 
Coxiella burnetii, an obligate intracellular bacterial pathogen that causes Q fever, 
undergoes a biphasic developmental cycle that alternates between a metabolically-
active large cell variant (LCV) and a dormant small cell variant (SCV). As such, the 
bacterium undoubtedly employs complex modes of regulating its lifecycle, metabolism 
and pathogenesis. Small RNAs (sRNAs) have been shown to play important regulatory 
roles in controlling metabolism and virulence in several pathogenic bacteria. We 
hypothesize that sRNAs are involved in regulating growth and development of C. 
burnetii and its infection of host cells. To address the hypothesis and identify potential 
sRNAs, we subjected total RNA isolated from Coxiella cultured axenically and in Vero 
host cells to deep-sequencing. Using this approach, we identified fifteen novel C. 
burnetii sRNAs (CbSRs). Fourteen CbSRs were validated by Northern blotting. Most 
CbSRs showed differential expression, with increased levels in LCVs. Eight CbSRs 
were upregulated (≥2-fold) during intracellular growth as compared to growth in axenic 
medium. 
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B. Introduction 
     During infection, pathogenic bacteria must adapt to diverse and dynamic 
environments imposed by their host and regulate synthesis of a variety of molecules 
(DNA, RNA and proteins) needed to colonize, replicate and persist. This kind of 
regulation must be rapid, metabolically inexpensive and efficient. There is growing 
evidence that post-transcriptional control mediated by small RNAs (sRNAs) plays a 
significant role in bacterial regulation (1, 2). In pathogenic bacteria, sRNAs are known to 
coordinate virulence gene expression and also stress responses that are important for 
survival in the host (3, 4). Bacterial sRNAs are typically 100-400 bases in length and are 
categorized as cis-encoded sRNAs and trans-encoded sRNAs. Most cis-encoded 
sRNAs are located within 5′ untranslated regions (UTRs) of mRNAs and are transcribed 
in the antisense orientation to the corresponding mRNA. Cis-encoded sRNAs can 
expose or block a ribosome-binding site (RBS) by adopting different conformations in 
response to various environmental cues, thereby regulating translation. On the other 
hand, trans-encoded sRNAs are located in intergenic regions (IGRs). They share only 
limited complementarity with their target RNAs and are thought to regulate translation 
and/or stability of these RNAs (2). sRNAs can interact with mRNA or protein in order to 
bring about regulation, but a majority of them function by binding to mRNA targets. An 
example of a widely distributed and well-studied sRNA is 6S RNA. 6S RNA binds to 
RNA polymerase (RNAP)-σ70 complex and regulates transcription by altering RNAP‟s 
promoter specificity during stationary phase (5, 6). 
    Coxiella burnetii, the causative agent of Q fever, is classified as a Gram-negative 
obligate intracellular -proteobacterium. Human Q fever is generally a zoonosis acquired 
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by inhalation of contaminated aerosols and can present either as an acute or chronic 
disease. An acute case of Q fever typically ranges from an asymptomatic infection to an 
influenza-like illness accompanied by high fever, malaise, atypical pneumonia, myalgia 
and hepatitis. In approximately 2-5% of cases, chronic Q fever occurs and manifests as 
endocarditis, especially in patients with predisposing valvular defects (7). The 
pathogen‟s biphasic developmental cycle consists of two cellular forms. An infectious, 
dormant small cell variant (SCV) is spore-like and can endure adverse environmental 
conditions such as heat, pressure, UV light and desiccation. Following inhalation, 
Coxiella enters alveolar macrophages by endocytosis and generates a phagolysosome-
like vacuole termed a parasitophorus vacuole (PV). The PV interacts with 
autophagosomes for bacterial nutrition (8). At approximately 8 h post-infection, SCVs 
metamorphose to form metabolically active LCVs in the PV, with a doubling time of 
approximately 11 hours (9, 10). Following 6-8 days of intracellular growth, the PV 
reaches maturity and occupies almost the entire volume of the cell, and it is filled with a 
mixture of LCVs and SCVs. By approximately 12 days, the entire bacterial population 
has transformed into SCVs that are eventually released upon lysis of the host cell (10).  
     C. burnetii encounters various and sudden changes in environmental conditions 
during its life cycle, including a rapid upshift in temperature upon transmission from 
contaminated aerosols to the human lung, and a downshift in pH and an increase in 
reactive oxygen intermediates (ROIs) in the PV. All of these events are relevant to 
rapid, sRNA-mediated regulation (2). Recent reports have identified sRNAs in a variety 
of pathogenic bacteria, including Legionella pneumophila (11) and Streptococcus 
pyogenes (12). Reports have also shown the involvement of sRNAs in the pathogenesis 
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of Streptococcus pneumoniae, Salmonella spp., Yersinia pseudotuberculosis and 
Listeria monocytogenes (13-16).  
     The sRNAs of intracellular bacterial pathogens are poorly characterized, and there 
are no reports on sRNAs of C. burnetii. Thus, the aim of our study was to identify 
sRNAs associated with the bacterium‟s developmental cycle and host cell infection. 
Here, we describe a set of 15 novel Coxiella sRNAs identified by high-throughput 
sequencing of RNA (RNA-seq) isolated from distinct life stages and culture conditions.  
C. Materials and Methods 
Cultivation of C. burnetii. C. burnetii Nine Mile phase II (strain RSA439, clone 4) was 
propagated in African green monkey kidney (Vero) fibroblast cells (CL-81; American 
Type Culture Collection) grown in RPMI medium (Invitrogen Corp.) supplemented with 
10% fetal bovine serum at 37oC in a 5% CO2 atmosphere. Bacteria were purified from 
host cells using differential centrifugation, as previously described (17).  LCVs were 
harvested at 72 h post-infection from infected cells using digitonin (18). SCVs were 
harvested and prepared at 21 days post-infection (dpi), as previously described (19), 
and used to infect Vero cell monolayers for the production of synchronized bacterial 
cultures. C. burnetii was also cultivated axenically in ACCM2 at 37oC in a tri-gas 
incubator (2.5% O2, 5% CO2, 92.5% N2) with continuous shaking at 75 RPM (20). To 
generate LCVs, ACCM2 was inoculated with 10-d-old ACCM2-cultured bacteria, 
incubated 72 h, and isolated by centrifugation (10,000 x g for 20 min at 4oC), as 
previously described (9). SCV generation in ACCM2 was identical to LCVs except 
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bacteria were grown for 7 d, and then flask lids were tightened and cultured an addition 
at 14 d on the lab bench (~25oC) without replenishing the medium (21).  
RNA isolation and deep-sequencing. To isolate C. burnetii RNA from infected Vero 
cells, LCVs were prepared as above and treated with 40 µg/ml RNase A in RNase A 
digestion buffer [10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 5 mM EDTA] to reduce host 
cell RNA contamination. SCVs were prepared as above and used directly. Total RNA 
used in deep-sequencing was purified from LCVs and SCVs with a Ribopure kit 
(Ambion). Resulting RNAs were treated with excess DNase I to remove trace amounts 
of residual DNA using a DNA-free kit, as instructed by the manufacturer (Applied 
Biosystems). RNA was precipitated with 100% ethanol and enriched for bacterial RNAs 
by sequential use of MICROBEnrich (Ambion), MICROBExpress (Ambion) and Ribo-
Zero (Epicentre) kits to increase the relative level of C. burnetii RNA derived from Vero 
cell-propagated organisms and to exclude rRNAs, respectively. RNA from C. burnetii 
cells cultured in ACCM2 was done as for infected Vero cells, however, the 
MICROBEnrich (Ambion) step was omitted. RNA was quantified using a 
NanoPhotometer (Implen) and checked for integrity using a 2100 Bioanalyzer (Agilent 
Technologies). Sequencing libraries were prepared with a TruSeq RNA sample 
preparation kit (Illumina). Libraries were sequenced on an Illumina HiSeq 2000 (76 
cycles) at the Yale Center for Genome Analysis (West Haven, CT). Two independent 
samples were sequenced from all conditions, and sequencing statistics are given in 
Table 3-1. Deep sequencing data were submitted to the Sequence Read Archive (SRA) 
database, NCBI, and assigned the accession number SRP041556. 
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Table 3-1. Sequencing statistics. 
Sample Reads mapped Total reads % mapped 
ACCM2-LCV1 31,890,682 32,945,220 97 
ACCM2-LCV2 34,064,618 35,157,535 97 
ACCM2-SCV1 22,937,399 23,682,545 97 
ACCM2-SCV3 29,168,247 30,027,641 97 
VERO-LCV2 61,191,633 81,206,707 75 
VERO-LCV3 45,315,665 65,102,022 70 
VERO-SCV1 33,270,940 47,656,046 70 
VERO-SCV2 48,317,348 59,069,599 82 
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Mapping of sequencing reads and quantification of transcripts. Sequencing reads 
were mapped on the C. burnetii Nine Mile Phase I (RSA 493) genome (NC_002971.3) 
using BWA software (22). The algorithm was set to allow for two mismatches between 
76-nt reads and the genome sequence. Coverage at each nucleotide position was 
visualized using Artemis software (23). Expression values for each genomic location 
were calculated by determining the number of reads overlapping that region and 
normalizing it to the total number of reads in each library and the region‟s length. The 
average expression values obtained from two independent libraries per time point were 
denoted as Mean Expression Values (MEVs). Transcripts were qualified as sRNAs if 
they were 50-400 nt in length, had an MEV ≥ 5 times that of the flanking 50 nucleotides 
and did not correspond exactly to an annotated open reading frame (ORF). The 
presence of σ70 consensus promoters and rho-independent terminators was predicted 
using BPROM (24) and TranstermHP (25) software, respectively.  
Northern blot analysis. Northern blots were carried out using a NorthernMax kit 
(Ambion) as per manufacturer‟s instructions. Briefly, total RNAs of C. burnetii grown in 
Vero cells or ACCM2 were isolated by sequential use of Ribopure (Ambion) and DNA-
free (Applied Biosystems) kits and then precipitated with 100% ethanol. For quality 
control purposes, RNA samples were occasionally analyzed on denaturing acrylamide 
gels to check for RNA integrity. RNA degradation was not observed in samples used in 
the study (data not shown). RNA (3 µg per lane, except CbSR 2, where 1.7 µg RNA 
was used) was electrophoresed through 1.5% agarose-formaldehyde gels and blotted 
onto positively-charged BrightStar-Plus nylon membranes (Ambion). Membranes were 
then UV-cross-linked or chemically cross-linked by 1-ethyl-3-(3-dimethylaminopropyl) 
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carbodiimide (EDC) (Sigma-Aldrich), as previously described (26). Hybridizations were 
carried out using single-stranded RNA probes specific to each sRNA. RNA probes were 
generated by T7 promoter-mediated in vitro transcription of PCR products using a 
MEGAscript kit as instructed (Ambion), in the presence of biotin-labeled UTP (Bio-16-
UTP; Ambion). Finally, membranes were developed with a BrightStart BioDetect kit 
(Ambion) following the manufacturer‟s protocol, and visualized using a LAS-3000 
imaging system (Fujifilm). Densitometry was performed using ImageJ software (27). 
[Please see Table 3-2 and 3-3 for primers and probe details].  
D. Results 
Identification of C. burnetii sRNAs 
     To investigate the transcriptome profile of C. burnetii and to identify potential sRNAs, 
we first isolated RNA from LCVs and SCVs co-cultured in Vero cells as well as those 
cultured axenically in ACCM2 medium. cDNAs prepared from these RNAs were 
subjected to Illumina sequencing. This deep sequencing analysis resulted in roughly 23 
to 32 million reads from RNA isolated from C. burnetii cultured axenically, and ~47 to 81 
million reads from total RNA isolated from Vero co-cultures. On the whole, sequencing 
reads obtained from C. burnetii cultured in ACCM2 mapped well to the genome (97%). 
On the other hand, sequencing reads from total RNA isolated from bacteria cultured in 
Vero host cells mapped 76% and ~72.5% to the genome, respectively (Table 3-1). By 
analyzing the sequencing reads, we identified a total of 15 novel sRNAs, which will 
hereafter be referred to as CbSRs (Coxiella burnetii small RNAs) (Table 3-4). 
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Table 3-2. PCR primers used to make CbSR probes*.  
Primers Sequence 5' to 3' 
CbSR 1_Forward CTTTCTGAAGAGGTAATCACGAAG 
CbSR 1_Reverse TAATACGACTCACTATAGGGTCCCTACCAAGCAGTTCTGTC 
CbSR 2_ Forward GATGCTGTTCTTCGTAGGC 
CbSR 2_Reverse TAATACGACTCACTATAGGGCGGCTATCGCTTCTTTGC 
CbSR 3_ Forward AAACAAACCTTGATAGAAAGCG 
CbSR 3_Reverse TAATACGACTCACTATAGGGACTACTTGATATTCCCTCTTTACC 
CbSR 4_ Forward GATAGCGTGGTGGGAATCGGTTAC 
CbSR 4_Reverse TAATACGACTCACTATAGGGGGGTTTGGTGCGGTCAAGTGG 
CbSR 5_ Forward CGAAATGAAGAAAAGCAACTC 
CbSR 5_Reverse TAATACGACTCACTATAGGGGCTTGGACTTCCTCTAAATG 
CbSR 6_ Forward GTAACTACGGGCATTCCATCG 
CbSR 6_Reverse TAATACGACTCACTATAGGGCGGTACTAACGGTTTCTCAAGC 
CbSR 7_ Forward CTTACTAGGGGATTTTTTTTACTCG 
CbSR 7_Reverse TAATACGACTCACTATAGGGTCGTTAGTTGAAACATTGAACG 
CbSR 8_ Forward CGAGGTGCTTTAGCCATTG 
CbSR 8_Reverse TAATACGACTCACTATAGGGAGATTGTAACGAGACGATGAAG 
CbSR 9_ Forward GAGTACCGTTATAAACATGGATAC 
CbSR 9_Reverse TAATACGACTCACTATAGGGTGAAGATGGGTGGAAAGCC 
CbSR 10_ Forward TCTTTTAATGAAGCGGGAATGG 
CbSR 10_Reverse TAATACGACTCACTATAGGGGCAACATTGGCACGATGG 
CbSR 11_ Forward GACATAACTAGACATCAGGTG 
CbSR 11_Reverse TAATACGACTCACTATAGGGGATTGGCTGCTGTAATGG 
CbSR 12_ Forward TAGCTGAGGTCTCTAGGATCTTG 
CbSR 12_Reverse TAATACGACTCACTATAGGGGACCTTAGACTACCTCATTACGTTTAG 
CbSR 13_ Forward GTCGTTCCCGTGCGTAGG 
CbSR 13_Reverse TAATACGACTCACTATAGGGGCCGTCTGCTGTAGTATTGAAG 
CbSR 14_ Forward GCTTTGGGAGATGACCTTCGC 
CbSR 14_Reverse TAATACGACTCACTATAGGGGACCGTGAGGACAGCAGTTTG 
CbSR 15_ Forward GAATCGGGAGAAACACCAC 
CbSR 15_Reverse TAATACGACTCACTATAGGGTGCCTTTAGGAGGTCAGTC 
*The T7 promoter sequence is underlined 
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Table 3-3. Probes used in Northern blots and RPAs. 
Probes Sequence 5' to 3' 
CbSR 1 CTTTCTGAAGAGGTAATCACGAAGTTAGGAAACTTTATCTCATGGAGAGAGAA
AGGTCTAAGGACAGAACTGCTTGGTAGGGA 
CbSR 2 GATGCTGTTCTTCGTAGGCGGCTTGGCCGCTTGCCAACAACAGGATCGCACC
CATCAGGATAGACAAAATGGCGCTGTTACAACGCCCCACCCCGATGATCAAC
AAAAAGATAATATGCAAAGAAGCGATAGCCG 
CbSR 3 AAACAAACCTTGATAGAAAGCGCGCTAGATTCCCGCCTGCGCGCATAGACGT
CAACTTAAGGAGCGAGGTAAAGAGGGAATATCAAGTAGT 
CbSR 4 GATAGCGTGGTGGGAATCGGTTACGGAAGATCGTTCCTGCCATTCTGTCGCA
AATGTAGCCACTTGACCGCACCAAACCC 
CbSR 5 CGAAATGAAGAAAAGCAACTCTTGGCCTGTCAAATGCTGCAAGCACAGATCG
ATCCCTTGTTGATTGCGAAACTAACAGGACTTCATTTAGAGGAAGTCCAAGC 
CbSR 6 GTAACTACGGGCATTCCATCGCGGGTAGATTTAATCAGTCCTTTAAAAAAATTT
TGTTGCGCTGCTTGAGAAACCGTTAGTACCG 
CbSR 7 CTTACTAGGGGATTTTTTTTACTCGTTTTCAATTCTATTGAACCGTTCAATGTTT
CAACTAACGA 
CbSR 8 CGAGGTGCTTTAGCCATTGGGCAACCCGTTTATTGGACTAGTATGGATAGATT
AAATCAAAACAAATTGAGCATGCGAACTGAACAAAGAGATAAAAGGCCACGTC
AAATTCCTAAGTGAGAAAGAATGTTTTGCAGCTCGTTTCAGGTCTTGAAGAAG
CTTCATCGTCTCGTTACAATCT 
CbSR 9 GAGTACCGTTATAAACATGGATACCCACTAGGTTGATGTTAGGCATTTTTAAAA
AGAAATTCTTATTCGAAAAAACGATTTCTTCATCCATGCCGAACTGCGAAGGC
TTTCCACCCATCTTCA 
CbSR 10 TCTTTTAATGAAGCGGGAATGGTTGCCATTGGAAACGTGGAGATGCCAGTAG
ATATGATGCTGGGAGGACCAATGACGTCGGTAACAGGCCCATCGTGCCAATG
TTGC 
CbSR 11 GACATAACTAGACATCAGGTGTAACCAAACAATCACGGAGGATCGACAAATGA
GAAAAGCACTTGCTAGCGTTGTTGTAATTATATTTGCAGGCTTACTTTGCACG
AGTTTACTGACAATCTTTACAGGCAACTCATCAGGTAACCATTACAGCAGCCA
ATC 
CbSR 12 TAGCTGAGGTCTCTAGGATCTTGGTGGACAAGGAAGTCCTCGGTGTACTCTA
AACGTAATGAGGTAGTCTAAGGTC 
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CbSR 13 GTCGTTCCCGTGCGTAGGCCGTCTATCGATAGACAAAGAATCGAGGGCTTTC
ACGGCCGAAGTCACGGGAATCCCGGCTAAGAGGGGCTTGAAGAACACTAAC
GGTGTTTTTCTTAGCTCCTTAATCTGGGTCCCCCCGACTCGGCCGTGAAGGTT
TTGTATTCTTCAATACTACAGCAGACGGC 
CbSR 14 GCTTTGGGAGATGACCTTCGCTGTGAAAATGGGGGTACCGTTACAGGAGTTA
CTCATAAGAATTGCGGGCTAACCTGGGAGACTAATCCTCCCGAATTCAATTTT
TGCCCAAAGGGCCAAACAACAAACTGCTGTCCTCACGGTC 
CbSR 15 GAATCGGGAGAAACACCACTCTTAAAATTACTATTGAAACGATTACCCAAGCA
ATCTTCCTTGAAGAAAGTAGCAAGTAATCCTCACTATATCGAGATGACTGACC
TCCTAAAGGCA 
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Table 3-4. Novel C. burnetii sRNAs (CbSRs) identified by RNA-seq*. 
sRNA 
Left 
Enda 
Right 
Enda 
Size 
(nt) 
Strand 
Axenic 
LCV 
Axenic 
SCV 
Vero LCV 
Vero 
SCV 
Mean Expression Value (MEV) 
CbSR 1 12005 12117 113 F 15444.89 257.96 59710.85 711.00 
CbSR 2 75261 75503 243 R 7381.43 782.49 15719.76 5885.67 
CbSR 3 481609 481806 198 R 577.92 757.68 1703.55 1225.17 
CbSR 4 544387 544582 196 R 1392.97 644.14 4163.36 3433.46 
CbSR 5 702095 702304 210 R 3302.63 293.32 584.04 338.12 
CbSR 6 727878 728097 220 R 1776.92 332.35 778.38 401.85 
CbSR 7 657100 657198 99 F 808.27 158.84 103.52 176.22 
CbSR 8 866381 866666 286 R 8384.18 338.06 1867.89 508.76 
CbSR 9 973800 974012 213 F 370.36 276.08 763.43 484.25 
CbSR 
10 
1090006 1090228 223 R 7138.08 914.10 5713.77 1768.32 
CbSR 
11 
1327797 1328052 256 F 6428.52 922.77 4258.87 4309.17 
CbSR 
12 
1403153 1403300 148 R 4423.01 1477.31 434177.60 35288.85 
CbSR 
13 
1816997 1817305 309 F 3716.12 1186.83 1621.83 1206.80 
CbSR 
14 
1838698 1838886 189 R 790.92 451.29 3719.02 691.73 
CbSR 
15 
1878295 1878543 249 F 1054.67 298.45 205.01 396.01 
aNumbering according to NC_002971.3 
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     All 15 CbSRs were present in both LCVs and SCVs cultured in axenic medium as 
well as in Vero cells. Comparison of the MEVs of LCVs and SCVs indicates that most 
CbSRs are present at higher levels in LCVs regardless of culture conditions. CbSRs 
could be classified into three groups based on the relative location of their coding 
sequence on the genome. Specifically, group I includes sRNAs encoded entirely within 
an IGR; group II consists of sRNAs situated antisense to identified ORFs (antisense 
sRNA), and group III includes sRNAs that are ORF-derived (Fig. 3-1). A majority (eight 
of fifteen) of the identified sRNAs were antisense sRNAs. Sizes of the CbSRs ranged 
from 99-309 nt with a minimum MEV of ~104 and a maximum MEV of ~434,178 in at 
least one growth condition. BLAST analyses showed that all sRNAs were found only in 
Coxiella and most sRNAs were highly conserved within six available C. burnetii 
genomes (RSA 493, RSA 331, Dugway 5J108-111, Cb175 Guyana, CbuK Q154 and 
CbuG Q212) with ≥97% sequence identity. The exception was CbSR 8, which was only 
found in C. burnetii strains RSA493, RSA331 and Cb175 Guyana. Regions immediately 
upstream of all sRNAs possessed predicted σ70 consensus promoters (Table 3-5), and 
intrinsic (Rho-independent) terminators were predicted just downstream of seven 
sRNAs (Table 3-6), suggesting that these are bona fide sRNAs. 
Verification of sRNA candidates 
     The fifteen sRNA candidates identified by RNA-seq were further analyzed by 
Northern blotting of total RNAs from C. burnetii LCV or SCV morphotypes (Fig. 3-2). 
Northern blots were probed using strand-specific biotinylated RNA oligonucleotides 
specific to each sRNA. In each case, CbSRs produced distinct bands on the Northern 
blots, validating their existence in the transcriptome as well as the strand of origin in the  
73 
 
 
Figure 3-1. Linkage maps showing CbSR loci on the C. burnetii 
chromosome (black line). Red arrows indicate CbSRs and their relative 
orientation. Blue, grey and green arrows represent annotated, hypothetical 
ORFs and pseudogenes, respectively. CbSRs are classified into three groups 
based on their location relative to adjacent genes: A. Group I: CbSRs 
encoded within IGRs, B. Group II: CbSRs located antisense to identified ORFs 
and C. Group III: CbSRs that are ORF-derived. 
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Table 3-5. Putative σ70 promoters  of CbSRs identified upstream of sRNA coding 
sequences using BPROM (24).  
sRNA -35 box -10 box sRNA -35 box -10 box 
CbSR 1 TTTATA GATTGT CbSR   9 TTTAAT TACACT 
CbSR 2 TTTAAA TATATT CbSR 10 TTGTCT TATAAT 
CbSR 3 TTCTAA CAGGAT CbSR 11 TTTCAA TATCTT 
CbSR 4 TTGAGA TAGTCT CbSR 12 TTGTTA TATATT 
CbSR 5 TTATCA TGAAAT CbSR 13 TTGGAG TATAAT 
CbSR 6 TGGCCA TATAAT CbSR 14 TTGCTA TAAAAA 
CbSR 7 TTCACA GATAAT CbSR 15 TTATCA GATAAT 
CbSR 8 TGGCCA TATAAT 
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Table 3-6. Rho-independent terminators of CbSRs identified using TranstermHP (25)*. 
sRNA    Predicted terminator sequence 
CbSR   1 AGGGATCACCAACCCGGGGTGGTTATAGCAACCACCCCTTTTTTTTATTATT
A 
CbSR   2 CGCCTCAGTATGAAAGAAATCTCGGCCGTTGATGTCCGAGATTTCTTCATCT
AAACACAG 
CbSR   3 AAAGCCTAAGAAAAGCGCCATCGGTGTTTTTCTTAGCCCCC 
CbSR 10 ATCTACGTAAACAAAGCAGGCAAAATCCTCGAATCGGATCTGCCTGCTTTTT
TTTGAAGAAA 
CbSR 11 TGATTATTTCCCCCAGCCTAGTCTGTCCGTTGTAAAACGGCAGCTAGGCTGC
TTTCATTCCAGG 
CbSR 12 TTGTACTAATAAAGAGGACCGCTTTTGCGGTCCTTTTTTTTCTCACTT 
CbSR 13 GAGGGGCTTGAAGAACACTAACGGTGTTTTTCTTAGCTCCT 
*underlined are the sRNAs overlapping with terminator sequences. 
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Figure 3-2. Northern blot detection of CbSRs. RNA was isolated from 
LCVs (3 dpi) and SCVs (21 dpi) grown in ACCM2. Hybridizations were 
performed at high stringency using biotinylated oligonucleotide probes 
specific to each CbSR. 3 μg RNA was used for all lanes. Apparent sizes of 
the CbSRs, as calculated from Northern blots, are indicated. (Note: intensity 
of bands is not comparable between panels, since exposure times for each 
panel have not been optimized). 
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C. burnetii genome. However, CbSR 7 was not observed. We believe this was due to 
relatively low CbSR 7 transcript quantity that was undetectable by Northern analysis 
(28). 
     For most of the CbSRs, estimated band sizes on Northern blots corresponded to the 
sRNA lengths predicted by RNA-seq analysis. However, four out of fourteen CbSRs 
showed multiple bands on blots (e.g., CbSR 3, CbSR 8, CbSR 12 and CbSR 13). First, 
in the case of CbSR 3, a longer transcript (~300 nt) was observed, which could 
represent a primary transcript that is cleaved to give a mature sRNA of ~200 nt, as 
obtained by RNA-seq. A similar processing has been previously described for sRNAs of 
other bacteria (29, 30). Second, CbSR 8, CbSR 12 and CbSR 13 Northern blots 
revealed two bands in which the larger bands corresponded to sizes obtained by RNA-
seq, suggesting that the upper band is the actual sRNA. In CbSR 12, the molar ratios of 
the two different-sized bands observed varied between the LCV and SCV stages, 
possibly indicating different RNA processing, similar to what occurs with the SroF sRNA 
of E. coli (30). When transcript levels of the fifteen CbSRs were compared on blots, 
most had increased expression during the metabolically-active LCV phase with 
exceptions like CbSR 9 which was present in seemingly equal amounts in both 
morphotypes. 
     Northern blot signal intensity of most CbSRs corresponded to the MEVs obtained by 
RNA-seq (Table 3-4), with a few anomalies like CbSR 11, CbSR 12 and CbSR 13. 
Although the larger band (~300 nt) of CbSR 3 doesn‟t correspond well with RNA-seq 
MEV ratios, the lower (~200 nt) band does. Furthermore, signal intensities of CbSR 11 
and CbSR 12 bands on Northern blots, as a function of morphotype, were consistently 
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reversed relative to their deep sequencing MEVs with increased transcript level in SCVs 
rather than LCVs. Further investigation is required to determine the basis of these 
discrepancies.   
sRNAs up-regulated during intracellular growth 
     To search for sRNA regulators that are significantly up-regulated during a host cell 
infection, we compared expression levels of CbSRs from C. burnetii cultured in Vero 
host cells to those cultured axenically in ACCM2 (Table 3-4). Results showed eight 
CbSRs with increased MEVs in host cells (i.e., at least 2-fold higher) relative to axenic 
medium, including CbSR 1, CbSR 2, CbSR 3, CbSR 4, CbSR 9, CbSR 11, CbSR 12 
and CbSR 14. Northern hybridizations were performed on each of these CbSRs to 
confirm their existence and determine their levels under different growth conditions (Fig. 
3-3). The results observed were consistent with RNA-seq data. CbSR 12 showed a 
marked 24-fold higher level in Vero-grown C. burnetii suggesting a possible role in 
regulating a bacterial response related to intracellular survival. Other CbSRs that were 
markedly increased during intracellular growth included CbSR 2 and CbSR 4, which 
were 8-fold and 5-fold higher by MEV, respectively, compared to values obtained from 
axenically-grown C. burnetii.  
E. Discussion 
     Although C. burnetii is an obligate intracellular parasite in nature, its life cycle 
includes a endospore-like, dormant SCV morphotype that enables the bacterium to 
persist and survive outside of host cells. Given the disparate physical conditions 
encountered by Coxiella in the context of the environment and host, it is highly likely  
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Figure. 3-3. Northern blots showing CbSRs up-regulated (≥ 2 fold) in host cells 
relative to ACCM2. RNA was isolated from SCVs (3 dpi) grown in ACCM2 (A) and in 
Vero host cells (V). Hybridizations were performed at high stringency using biotinylated 
oligonucleotide probes specific to each CbSR. 3 μg RNA was used for all lanes. 
Apparent sizes of the CbSRs, as calculated from the Northern blots, are indicated. 
(Note: intensity of bands is not comparable between panels, since exposure times for 
each panel have not been optimized).  
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that the bacterium employs a rapid and efficient means of regulation to withstand the 
changing, harsh conditions. Recently, sRNAs have become increasingly recognized as 
modulators of gene expression, and their role in controlling stress response and 
virulence, directly or indirectly, has been shown in several bacteria (4, 31). Here, we 
describe a deep sequencing-based identification of sRNAs in C. burnetii. RNA-seq has 
been used previously on several other organisms to identify novel non-coding RNAs 
(32-34), but this is the first experimental evidence for, and identification of, sRNAs in C. 
burnetii.  
     Analysis of sRNA libraries generated from total RNA isolated from C. burnetii grown 
in Vero cells and in axenic medium led to the identification of fifteen novel sRNAs, 
referred to as CbSRs 1-15. To ensure that the identified sRNAs were authentic, we 
experimentally verified their existence using Northern blot analyses and identified their 
strand of origin. However, CbSR 7, although detected by RNAseq, was not detectable 
by Northern blot analysis (28). The lengths of most of the CbSRs estimated from 
Northern blots were in fairly good agreement with that determined by RNA-seq. 
Moreover, the CbSRs are unique to C. burnetii, and with the exception of CbSR 8, 
highly conserved among six strains of the bacterium. All CbSRs were independently 
detected in both morphotypes of Coxiella isolated from both Vero cells and ACCM2, but 
their levels changed as a function of growth conditions. These results strongly suggest 
that CbSRs play a regulatory role in the physiology of Coxiella. Not surprisingly, 
transcript levels of most CbSRs increased during growth phase (LCV) as compared to 
stationary phase (SCV). A similar observation has been reported in S. pyogenes, where 
transcript levels of most sRNAs are abundant at exponential and early stationary phase 
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as compared to late stationary phase (12). Based on these observations one could 
predict that CbSRs help regulate genes that are involved in metabolic functions. 
     When we compared the transcript levels of CbSRs obtained from Coxiella grown in 
host cells versus axenic medium, eight sRNAs were found to be at higher levels during 
intracellular growth. Of these, CbSR 12 is particularly striking with regards to its up-
regulation in the host cell, and is a current focus of research in our lab. The role of 
sRNAs in controlling pathogenesis and virulence has been reported in a number of 
bacteria, including L. monocytogenes (35), Salmonella typhimurium (36), and Vibrio 
cholerae (37). We hypothesize that these eight CbSRs are involved in regulating the 
bacterium‟s stress response in the intracellular niche. In addition to identification of 15 
novel sRNAs, we also identified the bacterium‟s RNase P RNA (encoded by rnpB), 
tmRNA (encoded by ssrA) and 6S RNA (encoded by ssrS) by RNA-seq. RNase P RNA 
and tmRNA are well-studied sRNAs that are conserved among all bacteria. Studies 
have shown that RNase P RNA is the ribozyme component of RNase P  that is involved 
in processing of 4.5S RNA and tRNA precursor molecules (38). On the other hand, the 
tmRNA rescues stalled ribosomes during translation and tags incompletely translated 
proteins for degradation (39). 6S RNA is known to associate with RNA polymerase and 
interfere with transcription, especially during stationary phase (40).  
     Interestingly, using in silico analysis we also discovered that C. burnetii lacks an 
apparent Hfq; an RNA chaperone that modulates translation of many mRNAs and also 
stabilizes interactions of sRNAs with target RNAs. Previous reports have shown that hfq 
null mutants of pathogens that normally possess Hfq show decreased growth rates, 
increased sensitivity to stress conditions and impaired virulence (41, 42). The 
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significance of this observation in C. burnetii is unclear. Either Coxiella‟s sRNAs are 
Hfq-independent, similar to many Gram-positive bacteria (43), or the bacterium possess 
an atypical Hfq, as reported for Borrelia burgdorferi (44).  
     In the past few years, sRNAs have been identified in many bacteria; however, there 
are few reports on characterization of their target(s). Various computational and 
experimental approaches have been employed in order to identify these targets (45). 
With the aim of predicting potential roles for the identified CbSRs, we used TargetRNA2 
software (46) to predict mRNA targets that could base pair with the sRNAs. However, 
none showed significant binding to a specific and prominent mRNA target. We can 
speculate on the roles of some of the sRNAs based on the location of their coding 
sequence relative to neighboring genes. In the case of antisense sRNAs, the RNA that 
they regulate could be the corresponding mRNAs. Further, most of the antisense and 
ORF-derived sRNAs are less abundant than intergenic sRNAs indicating that they 
preferably base-pair with mRNAs encoded nearby. Unfortunately, since most of these 
genes are pseudogenes or encode hypothetical proteins, their regulatory function is 
difficult to predict based on location alone. Interestingly, CbSR 14 is transcribed 
antisense to the 5‟ UTR of trmE, a bacterial tRNA modification GTPase that has been 
implicated in ribosome assembly and other cellular processes including stress 
response, sporulation and pathogenesis (47). Since these functions would likely be 
advantageous to C. burnetii, CbSR 14 possibly regulates trmE, however, this 
hypothesis must be experimentally validated.  
     In conclusion, this study is the first step towards elucidating sRNA-mediated 
regulation of C. burnetii‟s physiology and pathogenesis. Further investigations are 
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required to determine the exact role played by each CbSR to help C. burnetii transition 
between the two different cell morphotypes and adapt to the intracellular niche.  
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CHAPTER FOUR 
Investigation of Coxiella burnetii’s 6S RNA and examination of its regulatory role 
in growth and development 
As published in part in: PLoS One. 2014 Jun 20;9(6):e100147. doi: 
10.1371/journal.pone.0100147 
A. Introduction 
     6S RNA was first identified in E. coli, where it was found to accumulate during 
stationary phase and interact with the RNA polymerase (RNAP)-σ70 complex (2). 6S 
RNA forms an extended hairpin structure that is highly conserved among eubacteria, 
consisting of a single-stranded central bubble that resembles an open promoter, flanked 
by a closing stem and terminal loop (4). As a result, 6S RNA associates with RNAP and 
occupies the active site, thereby interfering with formation of a transcription initiation 
complex (4) and blocking transcription. Apart from its role in transcription, functions of 
6S RNA also include: upregulation of genes involved in stress response and nutrient 
acquisition (5), long-term survival during stationary phase (6) and regulation of relA and 
ppGpp synthesis during the stringent response (7). In E. coli, 6S RNA is a major 
regulator of transcription; negatively affecting 148 genes while activating transcription of 
125 genes (8). In L. pneumophila, a close relative of C. burnetii, 6S RNA positively 
regulates several genes, many of which enhance intracellular growth and virulence (5).  
Early work by our lab showed a prominent RNA of ~200 nt in length that was more 
prominently expressed in SCVs compared to LCVs and eventually identified as 6S RNA 
(Fig. 4-1).  We mapped the ssrS gene by in silico analysis and unpublished 6S RNA  
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Figure 4-1. C. burnetii total RNA separated on a denaturing acrylamide 
gel. RNA isolated from C. burnetii LCVs (3 dpi) and SCVs (14 dpi) grown in 
Vero host cells was separated on a denaturing 8 M urea - 8% acrylamide gel 
and stained with ethidium bromide (5 µg RNA per lane). Arrow indicates the 
position of 6S RNA at ~200 nucleotides. The number of nucleotides in the 
RNA size standards (Std) is indicated to the left. 
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sequence data [kindly provided by Ronald Breaker (4)]. The ssrS gene is located in the 
5′ untranslated region (UTR) of C. burnetii’s ygfA locus (encoding formyl 
tetrahydrofolate cyclo-ligase; CBU_0066) (Fig. 4-2), a linkage that is highly conserved 
among α and γ-proteobacteria (4). Here, we characterize the 6S RNA of C. burnetii. We 
found that 6S RNA specifically binds to C. burnetii‟s RNAP, reaches its highest 
concentration in SCVs, and its expression is markedly increased during intracellular 
versus axenic growth.  
B. Materials and Methods 
Cultivation of C. burnetii. C. burnetii Nine Mile phase II (strain RSA439, clone 4) was 
propagated in African green monkey kidney (Vero) fibroblast cells (CL-81; American 
Type Culture Collection) grown in RPMI medium (Invitrogen Corp.) supplemented with 
10% fetal bovine serum at 370C in a 5% CO2 atmosphere. Bacteria were purified from 
host cells using differential centrifugation, as previously described (9). LCVs were 
harvested at 72 h post-infection from infected cells using digitonin (10). SCVs were 
harvested and prepared at 21 days post-infection (dpi), as previously described (11), 
and used to infect Vero cell monolayers for the production of synchronized bacterial 
cultures. C. burnetii was also cultivated axenically in ACCM2 at 370C in a tri-gas 
incubator (2.5% O2, 5% CO2, 92.5% N2) with continuous shaking at 75 RPM (12). To 
generate LCVs, ACCM2 was inoculated with 10-d-old ACCM2-cultured bacteria, 
incubated 72 h, and isolated by centrifugation (10,000 x g for 20 min at 40C), as 
previously described (11). SCV generation in ACCM2 was identical to LCVs except 
bacteria were grown for 7 d, and then flask lids were tightened and cultured an 
additional 14 d on the lab bench (~250C) without replenishing the medium (13). 
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Figure 4-2. Linkage map showing the location of C. burnetii’s 6S RNA 
gene (ssrS). ssrS is encoded in the 5' untranslated region (UTR) of ygfA 
(encoding formyl tetrahydrofolate cyclo-ligase; CBU_0066). The gene 
immediately upstream (CBU_0067) encodes a hypothetical protein. 
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Northern Blot Analysis. Northern blots were carried out using a NorthernMax kit 
(Ambion) as per manufacturer‟s instructions. Briefly, total RNAs of C. burnetii grown in 
Vero cells or ACCM2 were isolated by sequential use of Ribopure (Ambion) and DNA-
free (Applied Biosystems) kits and then precipitated with 100% ethanol. RNA (3 µg per 
lane) was electrophoresed through 1.5% agarose formaldehyde gels and blotted onto 
positively-charged BrightStar Plus nylon membranes (Ambion). Membranes were then 
UV cross-linked or chemically cross-linked by 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) (Sigma-Aldrich), as previously described (14). Hybridizations were 
carried out using single-stranded RNA probes specific to 6S RNA (Table. 4-1). 6S RNA 
probes were generated by T7 promoter-mediated in vitro transcription of PCR products 
(PCR primers, Table 4-2) using a MEGAscript kit, as instructed (Ambion), in the 
presence of biotin-labeled UTP (Bio-16-UTP; Ambion). Finally, membranes were 
developed with a BrightStart BioDetect kit (Ambion) following the manufacturer‟s 
protocol, and visualized using a LAS-3000 imaging system (Fujifilm). Densitometry was 
performed using ImageJ software (15). 
Quantitative PCR (qPCR) and quantitative real-time PCR (qRT-PCR). qPCR was 
performed as previously described (16) using a primer set specific to C. burnetii‟s rpoS 
gene (Table 4-3) for generation of a growth curve showing genome numbers as a 
function of time (11). Primers specific to C. burnetii‟s 6S RNA encoding gene (ssrS) 
(Table 4-3) were designed using Beacon Designer 7.5 software (Biosoft International). 
qRT-PCR data were obtained with a 6S RNA primer set and normalized to 
corresponding C. burnetii genome numbers.  
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Table 4-1. Probes used in Northern blots and RPAs. 
Probe Sequence 
6S RNA 
AATATAAGTGTATCCTCTGTGACTCGTGGCAAGGACCACATATTTGAACCGATAC
GAATATGATAGGGAATTGGCTGTGGTCACACTGTTGAGCAAGCCCGTTTTCGGG
GTCTCATAACC 
5S RNA 
CCACCTGATTCCATTCCGAACTCAGAAGTGAAAACGCTTAGCGCCGATGATAGT
GTGGGTCTCCCATGCGAAAGT 
 
 
Table 4-2. PCR primers and their sequence* 
Primers Sequence 
6SRNA_Forward AATATAAGTGTATCCTCTGT 
6SRNA_Reverse TAATACGACTCACTATAGGGGTTATGAGACCCCGAAAAC 
5SRNA_Forward CCACCTGATTCCATTCCGAACTCAGAAG 
5SRNA_Reverse TAATACGACTCACTATAGGGACTTTCGCATGGGAGACC 
*The T7 promoter sequence is underlined.  
 
Table 4-3. qPCR and qRT-PCR primers. 
Primers Sequence 5' to 3' Source or Reference 
6S_Forward ACCCCTAAGGGAAGCCTGAA This study 
6S_Reverse TTGAACCCAAAGGCTCAAGTG This study 
RpoS_Forward CGCGTTCGTCAAATCCAAATA (11) 
RpoS_Reverse GACGCCTTCCATTTCCAAAA (11) 
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C. burnetii extract preparation. A mixed population (11 dpi) of C. burnetii grown in 
Vero cells was pelleted by centrifugation (10,000 x g for 10 min at 4oC) and 
resuspended in 250 µl Net2 buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 0.05% NP-40 
(triton X-100)] supplemented with protease inhibitor (Complete Mini Protease inhibitor 
cocktail tablets used as instructed; Roche). RNasin Plus (Promega) was added to a final 
concentration of 1 U/µl and bacteria were lysed by five alternating freeze-thaws cycles 
in liquid nitrogen and a 37oC water bath (5 min each). The resulting lysate was clarified 
by centrifugation (10,000 x g for 10 min at 4oC), and the supernatant was used for 
further analysis. 
Immunoprecipitation (IP). Protein A Sepharose (PAS) beads (CL-4B; GE Healthcare) 
were swelled (2 mg PAS in 100 µl Net2 buffer) for 30 min at room temperature and 
washed three times with 400 µl cold Net2 buffer followed by centrifugation (400 x g for 
30 sec). IPs were carried out using rabbit anti-Escherichia coli RNAP core polyclonal 
antibody (a generous gift from Dr. Karen Wassarman, University of Wisconsin-
Madison), a corresponding rabbit pre-immune serum or rabbit anti-Coxiella Com1 
polyclonal antibody. Antibodies were incubated with 100 µl PAS-Net2 at a 1:50 dilution 
for 16 h at 4oC with gentle agitation. PAS-antibody conjugates were then washed five 
times with 400 µl cold Net2 buffer, as above. C. burnetii extract (25 µl) was added to 
each PAS-antibody conjugate and incubated for 2 h at 4oC with rocking. IP reactions 
were separated by centrifugation, and PAS beads and supernatants were retained for 
further analysis. PAS beads were washed five times as above, and the final pellet 
resuspended in Net2 buffer (200 µl). Approximately 20% of the IP suspension was used 
for protein analysis and 80% for RNA analysis.  
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Protein analysis.  IP beads and supernatants were mixed with equal volumes of 2X 
Laemmli sample buffer, boiled for 5 min and centrifuged 1 min at 16,000 x g. The 
resulting supernatants were resolved on a 10% acrylamide SDS-PAGE gel. The gel was 
immediately blotted onto a nitrocellulose membrane (0.45 µm pore size) and blocked for 
2 h at room temperature in blocking buffer [5% nonfat dry milk in TBS-T (25 mM Tris-
HCl, pH 8.0; 125 mM NaCl; 0.1% Tween 20)] with rocking. Blots were subsequently 
probed for 16 h with a 1:2000 dilution of anti-RNAP antibody in antibody binding buffer 
(TBS-T containing 1% nonfat dry milk) followed by 5 washes of 10 min each in TBS-T. 
Blots were then incubated for 1 h at room temperature with rocking in a 1:2000 dilution 
of peroxide-conjugated goat anti-rabbit IgG antibodies (Sigma) in antibody binding 
buffer, followed by 5 washes (10 min each) in TBS-T. Finally, blots were developed 
using a chemiluminescent substrate as instructed by the manufacturer (SuperSignal 
West Pico kit, Thermo Scientific) and visualized using a LAS-3000 imaging system 
(Fujifilm). 
RNA extraction and RNase Protection Assay (RPA). Total RNA from IP beads and 
supernatant was isolated by extraction with phenol:chloroform:isoamyl alcohol [25:24:1 ; 
v/v; (pH 8-8.3)] (Invitrogen) followed by ethanol precipitation. Purified RNA was 
processed using an RNase Protection assay (RPA) III kit (Ambion) as per 
manufacturer‟s instructions. Specifically, 43 ng of RNA and 4.3 pg of probe were used in 
each reaction, except in the IP from the anti-Com1 antibody, where 22.8 ng RNA was 
used. The 6S RNA probe prepared for Northern blot analysis was also used in RPAs. 
RPA reactions were resolved on gels (5% acrylamide; 8 M urea), transferred to 
BrightStar-Plus nylon membrane (Ambion) and UV-cross-linked. RPA blots were 
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developed using a BrightStar BioDetect kit as instructed (Ambion) and visualized with a 
LAS-3000 imaging system (Fujifilm) [Please see Table 4-1 for probe details]. 
Construction of 6S-overexpression and knockdown vectors 
The pKM244 plasmid (provided by Jim Samuel, Texas A&M University), a derivative of 
pKM230 (17), was used to generate the 6S-knockdown plasmid, p6Skd. An IPTG-
inducible lac promoter (Plac) and lac operator (lacO) were PCR amplified from pUC19 
plasmid using Plac_lacO+EcoRI Forward and Plac_lacO+NcoI Reverse primers Table 
4-4) and ssrS was PCR amplified from NMII genomic DNA using 6S antisense 
For_XmaI and 6S antisense Rev_NcoI. The amplified ssrS gene of C. burnetii was 
ligated to Plac_lacO, in the opposite orientation with respect to the lac promoter, to 
generate a Plac_lacO+6Santisense amplicon. The p6Skd plasmid was generated by 
ligating Plac_lacO+6Santisense and pKM244 following digestion with EcoRI and XmaI 
thereby cloning the ssrS gene into the multiple cloning site of pKM244 to take 
advantage of its tac promoter. The 6S-overexperssion plasmid, p6Sovrexp, was 
generated by Linda D. Hicks of our lab, using the same principle except that the ssrS 
gene was ligated to Plac_lacO in the same orientation with respect to the lac promoter 
to generate Plac_lacO+6Ssense, which was ligated into pKM244 as described above.  
Isolation of 6S-overexpression and knockdown clones 
C. burnetii was axenically cultured in ACCM2 from an inoculum of 2 X 106 genome 
equivalents per ml for 7 d at 370C in a 2.5% O2 and 5% CO2 environment, as previously 
described (12). Bacterial cells were washed five times in cold 10% glycerol and 
resuspended in the same, at an approximate concentration of 1011 cells/ml. C. burnetii  
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Table 4-4. Primers used for cloning ssrS. 
Primers Sequence 
Plac_lacO+EcoRI Forward TTTTGAATTCTTTACACTTTATGCTTCC 
Plac_lacO+NcoI Reverse TTTCCATGGAATTGTTATCCGCTCAC 
6S antisense For_XmaI TTTCCCGGGAATATAAGTGTATCCTCTGT 
6S antisense Rev_NcoI TTTCCATGGTTGAATACATAAAACCCTCT 
6S sense For_NcoI TTTCCATGGAATATAAGTGTATCCTCTGT 
6S sense Rev_XmaI TTTCCCGGGTTGAATACATAAAACCCTCT 
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was mixed with 3.78 µg of p6Skd or pKM244 and electroporated at 1.8 kV, 400Ω and 25 
µF as previously described (12). C. burnetii transformants were rescued in 6 ml ACCM-
2 containing 1% fetal bovine serum (FBS) and incubated overnight before addition of 
chloramphenicol (final concentration 3 µg/ml). Transformants were cultured for 7 d and 
a 10 µl aliquots were plated on chloramphenicol (3 µg/ml) containing ACCM-2 agarose. 
The clonality of the transformants was confirmed by performing two rounds of serial 
dilution followed by plating on chloramphenicol (5 µg/ml) containing ACCM2. At each 
stage, the expression of mCherry was monitored by microscopy. Plasmid preparations 
were performed on C. burnetii NMII transformed with p6Skd or p6Sovrexp and were 
sequenced to confirm plasmid content and orientation of ssrS  
IPTG induction experiments using C. burnetii NMII ssrS clones  
C. burnetii strains harboring p6Skd, p6Sovrexp or pKM244 were used to examine the 
IPTG inducibility of the plasmids. ACCM2 (20 ml) was inoculated with 106 GE/ml of each 
clone and cultured for 3 d at 370C in 2.5% O2 and 5% CO2 with shaking, as previously 
described (12). Culture volumes were then divided and one half supplemented with 1 
mM IPTG. Cells were isolated at 24 h and 48 h post-induction by centrifugation at 
16,000 x g for 16 min at 40C. DNA and RNA were isolated from the cells using a 
DNeasy Blood and Tissue kit (Qiagen) and Ribopure kit (Amibion), respectively, as per 
manufacturer‟s instructions. Resulting RNA was treated with TURBO DNase (Ambion), 
precipitated with 100% ethanol and quantified by spectrophotometry. 50 ng of RNA from 
each growth time-point was converted into cDNA using an iScript cDNA synthesis kit 
(Bio-Rad), as instructed by the manufacturer. Genome numbers were determined by 
qPCR with a primer set specific to the C. burnetii rpoS gene (11). cDNA was used to 
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perform qRT-PCR with ssrS primers (Table 4-3), as previously described (16). Amplified 
cDNA was normalized to the respective genome numbers. 
IPTG induction experiment using E. coli ssrS clones 
E. coli (TOP10F') was transformed with p6Skd, p6Sovrexp and pKM244 as instructed 
by the manufacturer (Invitrogen). Resulting E. coli strains were grown overnight at 370C 
in Luria-Bertani (LB) broth containing 5 µg/ml chloramphenicol (LBcam). These cultures 
were used to inoculate fresh LBcam at a 1:10 (v/v) dilution, and the mixture was grown 
to mid-logarithmic phase (2 h) at 370C.  IPTG was added to 1 mM and cells were 
isolated following 2 h growth at 370C with shaking. DNA and RNA were isolated using 
DNeasy Blood and Tissue kit (Qiagen) and Ribopure kit (Ambion), respectively, as per 
manufacturer‟s instructions. Resulting RNA was treated with TURBO DNase (Ambion), 
precipitated with 100% ethanol and quantified by spectrophotometry. RNA (500 ng) was 
converted to cDNA using an iScript cDNA synthesis kit (Bio-Rad), as instructed by the 
manufacturer. Genome numbers were determined by quantitative PCR (qPCR) with a 
primer set specific to the E. coli 16S rDNA. cDNA was used to perform qRT-PCR with 
the ssrS primer set (Table 4-3), as previously described (16). Amplified cDNA was 
normalized to the respective genome numbers. 
C. Results 
Characterization of C. burnetii’s 6S RNA 
     The ssrS gene of C. burnetii was mapped to the 5′ UTR of ygfA (Fig. 4-2). A linkage 
of ssrS and ygfA is conserved among many bacterial species (4). Also, the predicted 
secondary structure of the C. burnetii 6S RNA was found to be highly similar to the 
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published consensus structure of 6S RNA, consisting of a single-stranded central 
bubble, including two conserved G-C base pairs surrounding the bubble on both sides, 
flanked by a closing stem and terminal loop (Fig. 4-3) (4). The central bubble mimics the 
structure of a DNA template in an open promoter complex and also occupies the active 
site of the RNAP. These observations suggest that the 6S RNA of C. burnetii is 
functional.  
    To confirm the identity of the presumed 6S RNA band, we performed Northern blot 
analyses of RNA isolated from both morphotypes of C. burnetii cultured in Vero cells 
and in ACCM2. Northern blot analyses were also performed on total RNA isolated from 
SCVs at 14 dpi and 21 dpi to compare 6S RNA levels at early and late stationary phase. 
Blots were then probed with a biotinylated RNA designed from the 5 ′ UTR of C. 
burnetii’s ygfA locus. The resulting Northern blot validated the identity of 6S RNA and 
the size was observed to be ~185 nt, which we later confirmed by RNA-seq (not 
shown). Furthermore, 6S RNA was found to accumulate in SCVs relative to LCVs, 
irrespective of growth conditions (Fig. 4-4). This is similar to the 11-fold increase 
reported for E. coli 6S RNA during stationary phase versus exponential phase (2). 
Levels of 6S RNA in C. burnetii cultured in Vero cells were ~9-fold higher in SCVs at 14 
dpi compared to LCVs at 3 dpi when blots were analyzed by densitometry. Levels of 6S 
RNA dropped ~2 fold between 14 dpi and 21 dpi (Fig. 4-4, lane 1 compared to lanes 2 
and 3). On the other hand, the transcript level of 6S RNA in C. burnetii cultured 
axenically was ~2-fold higher in SCVs at 14 dpi compared to LCVs at 3 dpi and then 
remained stable through 21 dpi (Fig. 4-4, lane 4 compared to lanes 5 and 6). To further 
analyze the increased transcript level of 6S RNA during the SCV phase, we used qRT- 
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Figure 4-3. Predicted secondary structure of C. burnetii’s 6S RNA as 
determined by Centroidfold (1). The color scale at the bottom represents a 
heat color gradation from blue to red, corresponding to base-pairing 
probability from 0 to 1, respectively. The free energy of the structure is also 
shown. 
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Figure 4-4. Northern blots showing 6S RNA levels of C. burnetii. 
RNA was isolated from LCVs at 3 days post-infection (dpi) and SCVs 
(SCV
14
, 14 dpi; SCV
21
, 21 dpi) grown in Vero host cells and ACCM2, 
respectively. Hybridizations were performed at high stringency using a 
6S RNA-specific biotinylated oligonucleotide probe. 3 µg RNA was used 
for all lanes. The size of the signal is indicated to the left. 
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PCR to quantify and compare C. burnetii genome numbers to 6S RNA levels over a 14-
d infection period in Vero cells (Fig. 4-5A). Results showed the greatest increase (~6-
fold) in 6S RNA at 14 d as compared to 0 d of the infection period (Fig. 4-5B). When 6S 
RNA levels were compared between SCVs isolated from infected Vero cells versus 
axenic cultures, a ~7-fold higher transcript level was observed in SCVs isolated from 
Vero cells (Fig. 4-4, lanes 2 versus 5) indicating a potential role for 6S RNA during 
intracellular growth. A similar observation has been reported for L. pneumophila, where 
6S RNA was shown to be important for optimal expression of genes during intracellular 
growth (5).   
6S RNA Co-immunoprecipitates with RNAP 
     Previous studies with E. coli (2), Bacillus subtilis (18) and L. pneumophila (5) have 
shown a physical interaction between 6S RNA and RNAP. To investigate whether this 
interaction also exists in C. burnetii, we carried out IP studies using a C. burnetii lysate 
and antibodies that recognize E. coli‟s core RNAP subunits (a generous gift from Dr. 
Karen Wassarman, University of Wisconsin-Madison). When IP products were analyzed 
on western blots, two protein bands (~154 kDa and ~43 kDa) were observed that likely 
correspond to β/β΄ and α subunits of C. burnetii‟s RNAP, respectively (Fig 4-6A, lane 5), 
based on previous observations in E. coli IPs using the same antibody (2). These two 
bands were not observed in IPs carried out without antibody, irrelevant antibody (anti-
Coxiella Com1) or the corresponding pre-immune rabbit serum (Fig 4-6A, lanes 2-4, 
respectively) indicating that the antibody specifically recognizes C. burnetii‟s RNAP. 
RPAs on RNA prepared from IP samples showed that 6S RNA was present in IPs 
prepared using anti-RNAP antibody (Fig. 4-6B, lane 9) and was absent in controls,  
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Figure 4-5. C. burnetii 6S RNA copies per genome over a 14-d infection 
period. A. Number of C. burnetii genomes over a 14-d infection of Vero cells, as 
determined by qPCR with a primer set specific to rpoS. Values represent the 
means ± S.D. of the results of 6 independent determinations. B. Average 
number of copies of C. burnetii 6S RNAs per genome over a 14-d infection of 
Vero cells. The number of 6S RNA copies was determined by qRT-PCR using 
primers specific for 6S RNA and 1 µg total RNA from each time point using the 
same source cultures as in panel A. Values represent the means ± S.D. of the 
results of 6 independent determinations. Asterisks denote a significant 
difference relative to the 0-d sample (p<0.05 by student‟s t test) 
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Figure 4-6. 6S RNA co-immunoprecipitates with C. burnetii RNAP. A. 
Immunoblot showing IP reactions of a C. burnetii lysate and corresponding 
supernatant samples using various antibodies. IPs were performed with no 
antibody (lanes 2 and 6), rabbit anti-Coxiella Com1 antibody (lanes 3 and 7), 
pre-immune rabbit serum from the rabbit used to generate anti-RNAP 
antibodies (lanes 4 and 8) and rabbit anti-RNAP antibody (lanes 5 and 9). The 
presumed β/β′ and α subunits of RNAP are indicated to the right. Molecular 
weight values from standards are given to the left in kDa. An asterisk indicates 
the IgG heavy chain band in lanes 2-5. B. RPAs performed on IP samples. 
Specific biotinylated probes were used to detect samples containing 6S RNA 
and 5S RNA. 43 ng of RNA and 4.3 pg probe were used in each RPA reaction, 
except IP-anti-Com1, where 22.8 ng RNA was used. Lanes 1 and 3 contain 
untreated 6S RNA and 5S RNA probes, respectively, while lanes 2 and 4 
contain 6S RNA and 5S RNA probes plus RNase, respectively. The RNase-
protected portions of the 6S and 5S RNAs (6S‟ and 5S‟; respectively) are 
arrowed to indicate the presence or absence of corresponding signals in lanes 
5–13 
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indicating that 6S RNA co-immunoprecipitates with the core RNAP. Further, a 5S RNA 
control was detected in IP supernatants but was absent in IP samples, indicating that 
binding of 6S RNA to RNAP is specific.  
Overexpression and knockdown of C. burnetii’s 6S RNA 
     To determine the role of 6S RNA in regulating C. burnetii‟s transcriptome, we 
generated ssrS knockdown and overexpression strains of C. burnetii. The pKM244 
plasmid, a derivative of pKM230 (17), contains a mCherry gene (mChe) and 
chloramphenicol resistance marker cassette (CAT) and was used to generate 6S-
knockdown (p6Skd) (Fig. 4-7A) and 6S-overexpression (p6Sovrexp) (Fig. 4-7B) vectors. 
The expression of sense or anti-sense 6S RNA in the plasmid is driven by an IPTG-
inducible tac promoter (Ptac), while repression is maintained by a lac operator (lacO) 
and repressor (lacIq). These plasmids were first transformed into E. coli to test the 
IPTG-inducibility of the system. E. coli transformed with pKM244 was used as a vector-
only control. Following IPTG induction of 6S-knockdown and 6S-overexpression strains 
of E. coli, genomic DNA and Coxiella 6S sense/antisense RNAs were quantified using 
qPCR and qRT-PCR, respectively. Results showed that following IPTG-induction, levels 
of 6S sense/antisense RNA significantly (p < 0.02) increased, on a per genome basis 
(Fig. 4-8). On comparison of induced verses un-induced, the amount of 6S RNA 
increased up to ~4-fold in E. coli (p6Skd) and about ~8-fold in E. coli (p6Sovrexp) (Fig. 
4-8B), confirming the IPTG-inducibility of the constructs. Since the 6S primers used in 
qRT-PCR are specific to C. burnetii and not E. coli, no significant reads were obtained 
from E. coli transformed with pKM244 alone.  
109 
 
 
 
 
 
 
 
 
 
Figure 4-7. Schematic maps of the constructed shuttle vectors to: (A) 
knock down or (B) overexpress 6S RNA levels in C. burnetii. 
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Figure 4-8. Levels of 6S sense/antisense RNAs following IPTG-
induction of E. coli clones. (A) q-PCR data showing E. coli genome 
equivalents per ml (GE/ml). (B) qRT-PCR data showing numbers of 6S 
sense/antisense RNAs per genome in the presence or absence of 1 mM 
IPTG. Data represent the means of six independent experiments ± S.D. 
Asterisks denote statistically significant increases in 6S RNA levels in IPTG-
induced clones as compared to their un-induced counterparts (P < 0.02).    
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      To identify the set of genes that are regulated by 6S RNA, p6Skd, p6Sovrexp and 
pKM244 plasmids were transformed into axenically-cultured C. burnetii. Individual 
clones of these strains were isolated by multiple rounds of serial dilution followed by 
plating on ACCM2-agarose plates containing chloramphenicol (3 µg/ml). Verification of 
each clone‟s plasmid content was performed by PCR, mCherry expression (by 
fluorescence microscope) and a chloramphenicol-resistant phenotype. Plasmid 
preparations from these strains were also sequenced to confirm plasmid content and 
proper orientation of ssrS with respect to the lac promoter. Wild-type (WT) C. burnetii 
and C. burnetii (p6Skd, p6Sovrexp and pKM244) strains were cultured for 3 d, induced 
with 1 mM IPTG and samples were isolated at 24 h and 48 h post-induction. 
Unfortunately, results of qPCR and qRT-PCR showed highly variable levels of 6S RNA, 
on a per genome basis, with poor correlation of plasmid content and IPTG induction 
(Fig. 4-9). Furthermore, to determine if IPTG-inducibility of the C. burnetii strains was 
affected by time in culture, clones were also cultured for 1 d (log phase) and then 
induced with IPTG. DNA and RNA were purified from samples isolated at 24 h and 48 h 
post-induction and q(RT)-PCR was performed. However, the levels of 6S RNA were 
again inconsistent (data not shown), suggesting that these plasmids are not useful for 
this particular application in C. burnetii.  
D. Discussion 
     6S RNA is widely distributed among bacteria, and its biology has been under 
investigation since its identification in 1976 (19). Studies in E. coli (2), B. 
subtilis (18) and L. pneumophila (5) have shown that 6S RNA specifically associates 
with RNAP and regulates transcription. For example, some functions of 6S RNA include  
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Figure 4-9. Levels of C. burnetii 6S sense/antisense RNAs following IPTG-
induction. (A) q-PCR data showing C. burnetii genome equivalents per ml (GE/ml) 
at 24 h (blue) and 48 h post-induction (red). (B) qRT-PCR data showing numbers of 
6S sense/antisense RNAs following IPTG-induction for 24 h (green) and 48 h 
(orange). Levels of 6S RNA in the absence of IPTG and the cloning vector alone 
(pKM244) are also shown as a control. Data represent the means of three 
independent experiments ± S.D.   
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upregulation of genes involved in stress response and nutrient acquisition (5) , long-
term survival during stationary phase (6)  and regulation of relA and ppGpp synthesis 
during the stringent response (7). Considering C. burnetii’s intracellular niche, these 
functions would be clearly beneficial. This encouraged us to further investigate the 
biology of 6S RNA in C. burnetii. The ssrS gene of C. burnetii was mapped to the 5′ 
UTR of ygfA (Fig. 4-2). A linkage of ssrS and ygfA is conserved among many bacterial 
species (4). When we examined the transcript levels of 6S RNA in C. burnetii using 
Northern blot analysis, we found that it was present at much higher levels in the SCV 
stage of the bacterium, irrespective of growth conditions (Fig. 4-4). These results were 
also confirmed by qRT-PCR (Fig. 4-5). This increase is similar to what has been 
observed in other bacteria, where 6S RNA reaches its highest abundance during 
stationary phase (2, 5). Interestingly, a ~7-fold higher transcript level was observed in 
SCVs during intracellular versus axenic growth (Fig. 4-4, compare lanes 2 and 5). A 
similar observation has been reported for L. pneumophila, a bacterium that is closely 
related to C. burnetii. In fact, deletion of the ssrS gene of L. pneumophila reduced 
intracellular growth in host cells by ~10-fold, while there was no effect on the mutant‟s 
growth in axenic medium (5). A recent study in another pathogenic bacterium, Y. pestis, 
also showed increased transcript levels of 6S RNA in vivo (20). Also, the transcript level 
of 6S RNA in C. burnetii grown in Vero cells increased ~9-fold by 14 dpi (SCV), 
compared to 3 dpi (LCV), and then dropped ~2 fold at 21 dpi (SCV) (Fig. 4-4). However, 
this drop was not observed in C. burnetii grown axenically. It is possible that in Vero co-
cultures, some SCVs are still intracellular at 14 d (i.e. some Vero cells are extant), 
whereas by 21 d all the host cells are dead, SCVs are extracellular and 6S RNA falls to 
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a background level. Taken as a whole, our observations are suggestive of 6S RNA‟s 
involvement in regulating genes related to C. burnetii‟s stress response during 
intracellular growth.  
     Our studies have also shown that, similar to other bacteria, C. burnetii’s 6S RNA 
associates specifically with RNAP. This was demonstrated by IP experiments using a C. 
burnetii lysate and an antibody that recognizes core RNAP. Western blotting was 
performed to confirm that the antibodies were specific to C. burnetii’s RNAP (Fig. 4-6A). 
An RPA was also performed on RNA isolated from the IP samples using 6S RNA- and 
5S RNA-specific biotinylated probes. Results clearly showed that 6S RNA was present 
exclusively in IP samples where RNAP was present (Fig. 4-6B). This confirms a 
physical association between 6S RNA and RNAP. Based on these observations and 
previous research on other bacteria, we predict that 6S RNA alters transcription in C. 
burnetii by associating with its RNAP. The 6S RNA of E. coli is known to bind to all 
forms of RNAP, however, it preferentially interacts with RNAP-σ70 (21).  
     RpoS (σs) is classically the major starvation/stationary phase sigma factor, but it 
serves as the dominant sigma factor during exponential growth of C. burnetii (22). The 
choice of σs is thought to be due to the stressful conditions encountered by Coxiella in 
the context of the PV. With this in mind, we were curious about the potential targets of 
Coxiella‟s 6S RNA. Eight positively-charged amino acids have been shown to create a 
surface that is required for binding of 6S RNA to the 4.2 region of E. coli‟s RpoD (σ70) 
(3). Analysis of Coxiella‟s RpoS and RpoH 4.2 regions indicates that they each possess 
only five positively-charged amino acid residues (Fig. 4-10). This suggests that 
Coxiella‟s 6S RNA interactions with RNAP-RpoS and RNAP-RpoH would be minimal or  
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Figure 4-10. The 4.2 region of E. coli RpoD in comparison to predicted, 
homologous regions of C. burnetii sigma factors. E. coli (Ec) and C. 
burnetii (Cb) 4.2 regions of sigma factors RpoD, RpoS and RpoH are shown. 
Positively-charged amino acids of the E. coli sigma factor RpoD 4.2 region 
involved in binding 6S RNA (3) are shown in red. Positively-charged residues 
in the predicted 4.2 region of C. burnetii sigma factors are shown in green. 
ClustalW alignment results are shown on the bottom line, where an asterisk 
indicates perfect identity, a colon indicates similar amino acids with 
conservation and a period indicates weakly similar amino acids with 
conservation to the E. coli sequence. 
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absent. In contrast, the 4.2 region of Coxiella‟s RpoD (σ70) shares 100% identity with 30 
amino acid residues of the E. coli σ70 4.2 region with all eight positively-charged amino 
acids present (Fig. 4-10). Taken together, these analyses suggest that Coxiella‟s 6S 
RNA would mainly interact with RNAP-σ70. Nevertheless, the dominant role of RpoS in 
the log-phase growth of C. burnetii suggests the potential for an atypical mechanism of 
6S RNA-mediated gene regulation that warrants additional research. . 
    Early work with E. coli demonstrated that 6S RNA binding to RNAP-σ70 during 
stationary phase inhibits polymerase binding to certain σ70-dependent promoters, thus 
selectively regulating transcription [reviewed in (23)]. Later, it was revealed that the 6S 
RNA of E. coli also activates certain σs-dependent promoters [reviewed in (23)]. In 
contrast, the 6S RNA of L. pneumophila was found to serve mainly as a positive 
regulator of genes involved in amino acid metabolism, stress adaptation, DNA 
repair/replication and detoxification (5). Based upon these observations, we predict that 
C. burnetii‟s 6S RNA acts as both a positive and negative regulator as cells approach 
stationary phase (SCV stage). To identify the genes that are regulated by 6S RNA we 
generated 6S-knockdown and overexpression strains of C. burnetii using a pKM244 
shuttle vector. The transcription of 6S sense/antisense RNA was under the control of a 
tac promoter and subject to IPTG induction. These 6S-knockdown and overexpression 
plasmids were positively tested for their IPTG-inducibility in E. coli, where they showed 
significantly increased 6S sense/antisense RNA levels upon induction (Fig. 4-8). 
However, when IPTG-inducibility of these plasmids was tested in C. burnetii, the levels 
of 6S sense/antisense RNAs following induction were found to be highly variable with 
little correlation to plasmid content or IPTG treatment (Fig. 4-9). One possible 
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explanation for this unfortunate observation is that since C. burnetii‟s genome does not 
contain any constituents of the E. coli lac operon, IPTG induction may not be functional 
or is suboptimal in this bacterium. However, this explanation runs counter to a previous 
report of successful IPTG induction of a fusion protein encoded on this vector (24). 
Despite our attempts to use several time points in the growth cycle for IPTG induction of 
sense/antisense RNA, it is possible that the concentration and timing of IPTG induction 
may need to be further adjusted to optimize the system. An alternative is to generate 
different constructs where expression is under the control of one of the heat shock 
promoters of C. burnetii. 
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CHAPTER FIVE 
CONCLUSIONS 
     Small RNAs (sRNAs) are a group of non-coding RNAs that regulate a variety of 
processes in bacteria, including transcription, translation, and mRNA stability (1). The 
roles of these molecules are especially important in pathogenic bacteria where they 
regulate processes that are involved in controlling virulence and adapting to harsh 
environmental conditions (2). Since C. burnetii is an obligate intracellular bacterium in 
nature, these adaptations would be clearly beneficial. Therefore, the overarching goal of 
my research was to identify and characterize such regulatory RNA elements of C. 
burnetii and to elucidate the role of some of these RNA elements in C. burnetii‟s biology.  
     The RNA that we were initially interested in studying was the IVS element inserted in 
the 23S rRNA gene of C. burnetii (3). Similar to other parasitic genetic elements of C. 
burnetii, IVS is highly conserved among all the genotypes of this bacterium. Removal of 
the IVS element results in fragmentation of the 23S rRNA without affecting its function. 
In spite of its occurrence in one of the most conserved genes of bacteria, IVS 
distribution is sporadic, indicating that it is likely acquired by horizontal gene transfer (4). 
Due to C. burnetii‟s intracellular niche, it should have been shielded from such an event. 
However, a recent study has shown that the pathogenic C. burnetii evolved from a 
Coxiella-like progenitor hosted by ticks (5). Evolution from a tick symbiont to a virulent 
pathogen of vertebrates probably involved the acquisition of virulence factors through 
horizontal gene transfer from co-infecting pathogens (5). In the light of this scenario, it is 
possible that C. burnetii initially acquired the IVS element through horizontal transfer 
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before or during its transition to a vertebrate host. Thereafter IVS was possibly 
maintained within the genus by vertical transfer due to its adaptive role in growth 
modulation. 
     Similar to Leptospira, the IVS of C. burnetii contains an ORF that potentially encodes 
a hypothetical S23p protein (6). Additionally, orthologs of this protein are also encoded 
by the IVS ORFs of Haemophilus, Brucella and Xanthomonas (6). In spite of several 
attempts and various strategies, we were unable to express the C. burnetii S23p protein 
in vitro using a coupled transcription-translation system. Surprisingly, when the 
sequence of the IVS was investigated among several C. burnetii strains, we observed 
variability in nucleotide sequence, but maintenance of the stem portion of the element 
involved in fragmentation. This is indicative of reductive evolution of the ORF, akin to 
the pseudogenes of C. burnetii.  In fact, the ORF could eventually be eliminated by this 
bacterium. These observations led us to predict that IVS is not expressed in vitro and 
probably not in vivo. Therefore, we directed our attention to the IVS RNA.  
     The predicted secondary structure of the IVS was found to be a stem-loop structure 
held together by complementary sequences present on the ends. We showed that, 
similar to other bacteria, IVS in C. burnetii is excised by RNase III, an 
endoribonucleases that usually cleaves 23S and 16S from their rRNA precursor. 
Additionally, we were able to map the ends of the IVS following its cleavage by RNase 
III. To deduce the in vivo role of IVS RNA, we determined the in vivo half-life of IVS in 
an E. coli model and in C. burnetii. An extended half-life might indicate an adaptive role 
in C. burnetii (7). However, IVS was found to be degraded as soon as it was excised 
from the 23S rRNA in C. burnetii as well as in an E. coli model. These results are 
123 
 
consistent with previous observations in other bacteria where IVS was not detected by 
Northern analysis (8, 9).  
     Although fragmentation of 23S rRNA due to IVS removal doesn‟t affect its function, 
the degradation of these fragments might be altered. Studies in Salmonella have shown 
that increased fragmentation of 23S rRNA results in its increased degradation during 
stationary phase (10). However, when we analyzed the fragments of 23S rRNA of C. 
burnetii and compared them to 16S rRNA, the two fragments of 23S rRNA (F1 and F2) 
were differentially regulated. In fact, the levels of smaller 23S rRNA fragment F1 were 
significantly higher than 16S rRNA while that of larger 23S rRNA fragment F2 was 
significantly lower than 16S rRNA. These results show that F2 is more labile than F1, 
which may be as a result of its large size and the presence of two introns that need to 
be spliced out during maturation. Considering that equal numbers of rRNAs are 
incorporated into the ribosomes, F2 levels might dictate the number of mature 
ribosomes that are formed. It is conceivable that this limitation could contribute to 
growth modulation in C. burnetii. Therefore, differential stability of 23S rRNA, as a result 
of IVS-mediated excision, could contribute to slow growth rate and promote C. burnetii‟s 
tendency towards chronic infection.  
     Survival of C. burnetii within the intracellular environment and transitioning between 
the two development forms require quick and efficient regulation that is probably aided 
by sRNAs. In the recent decade, research on discovery and characterization of sRNAs 
has increased greatly. Genome-wide analyses using high-density tiling arrays and RNA-
seq have revealed the transcriptomes of various pathogenic bacteria and exposed a 
high abundance of sRNAs. Although these RNAs might initially appear as products of 
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spurious transcriptional events, recent reports have shown that they are functional and 
can be important regulators of gene expression (11). Using RNA-seq, we identified 15 
novel sRNAs (CbSR 1-15) of C. burnetii and confirmed their presence, size and strand 
of origin using Northern analyses. Most of the CbSRs were found to be elevated in the 
metabolic phase of the life cycle, indicating that they might play a role in physiology. 
The genes that are expressed during the LCV phase are probably involved in survival in 
the hostile environment. In many bacteria, sRNAs have been identified to be key 
components of regulatory cascades that manage environmental changes caused by 
changes in pH, concentration of reactive oxygen species and metabolic-by-products 
(12). Therefore, sRNAs that are highly expressed during the LCV stage might be 
involved in regulating such processes. Interestingly, when expression of CbSRs was 
compared between C. burnetii cultured in Veros and axenic medium, eight of them were 
found to be increasingly expressed during intracellular growth. The role of sRNAs in 
controlling pathogenesis had been reported in several bacteria (2). Therefore, these 
eight sRNAs could be involved in regulating Coxiella‟s virulence and stress response 
during Coxiella‟s survival within the hostile intracellular environment. The obvious next 
step is to determine the target(s) of these sRNAs to identify the genes that they 
regulate. One of the approaches that can be used to identify the target of these novel 
sRNAs is by computational prediction approaches using algorithms like RNApredator 
(13) and IntaRNA (14). The general approaches also include high-throughput screening 
of targets using genomics- and proteomics-based methods (15). Another probable 
method of target identification is monitoring the phenotypic changes resulting from 
experimental manipulation of sRNA transcript levels.  
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     In addition to identification of the novel sRNAs, we also identified the 6S RNA of C. 
burnetii. The ssrS gene was mapped to the 5' UTR of the yfgA locus. Interestingly, the 
secondary structure of 6S RNA of C. burnetii was found to consist of a central bubble 
flanked by a closing stem and terminal loop. The functional importance of this structure, 
especially the central bubble, has been reported for E. coli (16, 17). When the levels of 
6S RNA was analyzed over the growth cycle of C. burnetii, it was found to be highest 
during the SCV phase. This observation is similar to other bacteria where 6S RNA was 
highest during stationary phase of the organism (18).  
     To identify the role it plays in C. burnetii biology, we determined whether 6S RNA 
interacts with RNAP. Immunoprecipitation with antibodies that identify core RNAP 
showed that 6S RNA efficiently and specifically binds to the RNAP of C. burnetii. In E. 
coli, 6S RNA associates with σ70-RNAP holoenzyme and affects transcription by 
negatively regulating genes expressed from σ70 dependent promoters and positively 
affecting genes expressed from σS dependent promoters (19). When the 4.2 regions of 
the sigma factors of C. burnetii (σ70, σS, σ32) were compared for the presence of eight 
positively-charged amino acids that are known to be required for 6S RNA binding, σ70 
was found as the most probable candidate. However, contrary to other bacteria, σS is 
the dominant sigma factor during exponential growth of C. burnetii (20). Based on these 
observations we conclude that although 6S RNA of C. burnetii probably associates with 
σ70-RNAP, similar to other bacteria, its mode of regulation might be very different.  
     Additionally, 6S RNA of L. pneumophila and Y. pestis were found to be 
comparatively higher during intracellular growth (21, 22). In fact, 6S null mutants of L. 
pneumophila displayed reduced fitness during intracellular growth indicating that 6S 
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RNA functions in a way that is essential for surviving in a eukaryotic host (21). Due to 
the intracellular nature of C. burnetii, such as role would be clearly beneficial. Further, to 
identify the genes that are regulated by 6S RNA, we generated 6S-overexpression and 
6S-knockdown mutants of C. burnetii using a pKM244 shuttle vector. 6S RNA was 
sequentially cloned in either sense or antisense orientation with respect to a lac 
promoter to generate overexpression and knockdown constructs, respectively. The 
IPTG inducibility of these plasmids was first tested successfully in E. coli. These 
plasmids were then electroporated into C. burnetii and clones were isolated based on 
chloramphenicol resistance, mCherry expression and PCR confirmation of plasmid 
content. When the IPTG inducibility of these plasmids was tested in C. burnetii, the 
levels of sense and antisense 6S RNA expression was highly variable. Similar results 
were observed on repeating the experiment by altering the timing of IPTG induction of 
the strains indicating that these plasmids are not useful for this particular application in 
C. burnetii. Further, adjusting the concentration of IPTG might be required to optimize 
this system. Alternatively, a different construct could be generated where the expression 
of ssrS is under the control of a C. burnetii promoter such as CBU1169 that encodes a 
small heat shock protein Hsp20 or CBU0311, an outer membrane porin P1 promoter 
(23).  
     In conclusion, we have identified and confirmed 15 novel sRNAs of C. burnetii. 
Additionally, we have characterized two non-coding RNAs: IVS, a parasitic genetic 
element, and 6S RNA, a sRNA that regulates transcription. This is the first step towards 
elucidating the regulatory RNA networks of C. burnetii. Further work on these sRNAs 
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will reveal details of transcriptional regulation that will further our understanding of the 
physiology and virulence of this mysterious pathogen. 
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